Precision Atomistic Structures of Actinium-/Radium-/Barium-Doped Lanthanide Nanoconstructs for Radiotherapeutic ApplicationsClick to copy article linkArticle link copied!
- Monojoy GoswamiMonojoy GoswamiChemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United StatesMore by Monojoy Goswami
- Miguel Toro-GonzálezMiguel Toro-GonzálezRadioisotope Science & Technology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United StatesMore by Miguel Toro-González
- Jisue MoonJisue MoonRadioisotope Science & Technology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United StatesMore by Jisue Moon
- Sandra Davern*Sandra Davern*Email: [email protected]Radioisotope Science & Technology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United StatesMore by Sandra Davern
Abstract
Lanthanide vanadate (LnVO4) nanoconstructs have generated considerable interest in radiotherapeutic applications as a medium for nanoscale-targeted drug delivery. For cancer treatment, LnVO4 nanoconstructs have shown promise in encapsulating and retaining radionuclides that emit alpha-particles. In this work, we examined the structure formation of LnVO4 nanoconstructs doped with actinium (Ac) and radium (Ra), both experimentally and using large-scale atomistic molecular dynamics simulations. LnVO4 nanoconstructs were synthesized via a precipitation method in aqueous media. The reaction conditions and elemental compositions were varied to control the structure, fluorescence properties, and size distribution of the LnVO4 nanoconstructs. LnVO4 nanoconstructs were characterized by X-ray diffraction, Raman spectroscopy, and fluorescence spectroscopy. Molecular dynamics simulations were performed to obtain a fundamental understanding of the structure–property relationship between radionuclides and LnVO4 nanoconstructs at the atomic length scale. Molecular dynamics simulations with well-established force field (FF) parameters show that Ra atoms tend to distribute across the nanoconstructs’ surface in a broader coordination shell, while the Ac atoms are arranged inside a smaller coordination shell within the nanocluster. The Ba atoms prefer to self-assemble around the surface. These theoretical/simulation predictions of the atomistic structures and an understanding of the relationship between radionuclides and LnVO4 nanoconstructs at the atomic scale are important because they provide design principles for the future development of nanoconstructs for targeted radionuclide delivery.
This publication is licensed under
License Summary*
You are free to share(copy and redistribute) this article in any medium or format within the parameters below:
Creative Commons (CC): This is a Creative Commons license.
Attribution (BY): Credit must be given to the creator.
Non-Commercial (NC): Only non-commercial uses of the work are permitted.
No Derivatives (ND): Derivative works may be created for non-commercial purposes, but sharing is prohibited.
*Disclaimer
This summary highlights only some of the key features and terms of the actual license. It is not a license and has no legal value. Carefully review the actual license before using these materials.
License Summary*
You are free to share(copy and redistribute) this article in any medium or format within the parameters below:
Creative Commons (CC): This is a Creative Commons license.
Attribution (BY): Credit must be given to the creator.
Non-Commercial (NC): Only non-commercial uses of the work are permitted.
No Derivatives (ND): Derivative works may be created for non-commercial purposes, but sharing is prohibited.
*Disclaimer
This summary highlights only some of the key features and terms of the actual license. It is not a license and has no legal value. Carefully review the actual license before using these materials.
License Summary*
You are free to share(copy and redistribute) this article in any medium or format within the parameters below:
Creative Commons (CC): This is a Creative Commons license.
Attribution (BY): Credit must be given to the creator.
Non-Commercial (NC): Only non-commercial uses of the work are permitted.
No Derivatives (ND): Derivative works may be created for non-commercial purposes, but sharing is prohibited.
*Disclaimer
This summary highlights only some of the key features and terms of the actual license. It is not a license and has no legal value. Carefully review the actual license before using these materials.
License Summary*
You are free to share(copy and redistribute) this article in any medium or format within the parameters below:
Creative Commons (CC): This is a Creative Commons license.
Attribution (BY): Credit must be given to the creator.
Non-Commercial (NC): Only non-commercial uses of the work are permitted.
No Derivatives (ND): Derivative works may be created for non-commercial purposes, but sharing is prohibited.
*Disclaimer
This summary highlights only some of the key features and terms of the actual license. It is not a license and has no legal value. Carefully review the actual license before using these materials.
License Summary*
You are free to share(copy and redistribute) this article in any medium or format within the parameters below:
Creative Commons (CC): This is a Creative Commons license.
Attribution (BY): Credit must be given to the creator.
Non-Commercial (NC): Only non-commercial uses of the work are permitted.
No Derivatives (ND): Derivative works may be created for non-commercial purposes, but sharing is prohibited.
*Disclaimer
This summary highlights only some of the key features and terms of the actual license. It is not a license and has no legal value. Carefully review the actual license before using these materials.
Introduction
Results and Discussion
Conclusions
Methods
Experimental Section
Materials
Nanoparticle Synthesis
Characterization
Molecular Dynamics Simulations
Supporting Information
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.3c13213.
Description of MD simulations in detail; force-field parameters (Lennard-Jones) used in the MD simulations; RDF of water in LnVO4 and the comparison of the RDF of La, Eu, and oxygen of VO4; RDF of Ac-/Ra-doped lanthanide at different temperatures and the snapshots; Rietveld analysis parameters and XRD patterns; summary of the molar ratio of the nanoconstructs; excitation and emission spectra of 225Ac-doped nanoconstructs and 30 days' decayed 225Ac-doped nanoconstructs, respectively; and different compositions of lanthanides (PDF)
Terms & Conditions
Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.
Acknowledgments
This research was supported by the US Department of Energy’s (DOE’s) Oak Ridge National Laboratory Directed Research & Development (LDRD) Program. The isotopes used in this research was supplied by the U.S. Department of Energy Isotope Program, managed by the Office of Isotope R&D and Production. The MD simulations used resources of the Oak Ridge Leadership Computing Facility at Oak Ridge National Laboratory, which is supported by the DOE Office of Science of the U.S. DOE under Contract No. DE-AC05-00OR22725. Part of the MD simulations used resources of the National Energy Research Scientific Computing Center (NERSC), a DOE Office of Scientific User Facility supported by the DOE Office of Science under Contract No. DE-AC02- 05CH11231. The authors thank Christopher Orosco from ORNL’s Creative Services Communications Division for designing the Supplementary Cover Image for this work.
6-AHA | 6-aminohexanoic acid |
CAS | chemical abstracts service |
CTB | charge-transfer band |
DI | deionized |
DLS | dynamic light scattering |
FF | force field |
MD | molecular dynamics |
RDF | radial distribution function |
TEM | transmission electron microscopy |
TRT | targeted radionuclide therapy |
XRD | X-ray diffraction |
References
This article references 69 other publications.
- 1Kim, Y. S.; Brechbiel, M. W. An Overview of Targeted Alpha Therapy. Tumor Biol. 2012, 33, 573– 590, DOI: 10.1007/s13277-011-0286-yGoogle Scholar1https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsF2ntrw%253D&md5=c3688e4aa0b30e5923ba04e1e43bb86eAn overview of targeted alpha therapyKim, Young-Seung; Brechbiel, Martin W.Tumor Biology (2012), 33 (3), 573-590CODEN: TUMBEA; ISSN:1010-4283. (Springer)A review. The effectiveness of targeted α-therapy (TAT) can be explained by the properties of α-particles. Alpha particles are helium nuclei and are ∼8,000 times larger than β--particles (electrons). When emitted from radionuclides that decay via an α-decay pathway, they release enormous amts. of energy over a very short distance. Typically, the range of α-particles in tissue is 50-100 μm and they have high linear energy transfer (LET) with a mean energy deposition of 100 keV/μm, providing a more specific tumor cell killing ability without damage to the surrounding normal tissues than β--emitters. Due to these properties, the majority of pre-clin. and clin. trials have demonstrated that α-emitters such as 225Ac, 211At, 212Bi, 213Bi, 212Pb, 223Ra, and 227Th are ideal for the treatment of smaller tumor burdens, micrometastatic disease, and disseminated disease. Even though these α-emitters have favorable properties, the development of TAT has been limited by high costs, unresolved chem., and limited availability of the radionuclides. To overcome these limitations, more potent isotopes, addnl. sources, and more efficient isotope prodn. methods should be addressed. Furthermore, better chelation and labeling methods with the improvements of isotope delivery, targeting vehicles, mol. targets, and identification of appropriate clin. applications are still required.
- 2Pouget, J. P.; Constanzo, J. Revisiting the Radiobiology of Targeted Alpha Therapy. Front. Med. 2021, 8, 692436 DOI: 10.3389/fmed.2021.692436Google Scholar2https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB2cvktVWntA%253D%253D&md5=c94e3c94e7dc81a867ad3e5d13c9cff0Revisiting the Radiobiology of Targeted Alpha TherapyPouget Jean-Pierre; Constanzo JulieFrontiers in medicine (2021), 8 (), 692436 ISSN:2296-858X.Targeted alpha therapy (TAT) using alpha particle-emitting radionuclides is in the spotlight after the approval of (223)RaCl2 for patients with metastatic castration-resistant prostate cancer and the development of several alpha emitter-based radiopharmaceuticals. It is acknowledged that alpha particles are highly cytotoxic because they produce complex DNA lesions. Hence, the nucleus is considered their critical target, and many studies did not report any effect in other subcellular compartments. Moreover, their physical features, including their range in tissues (<100 μm) and their linear energy transfer (50-230 keV/μm), are well-characterized. Theoretically, TAT is indicated for very small-volume, disseminated tumors (e.g., micrometastases, circulating tumor cells). Moreover, due to their high cytotoxicity, alpha particles should be preferred to beta particles and X-rays to overcome radiation resistance. However, clinical studies showed that TAT might be efficient also in quite large tumors, and biological effects have been observed also away from irradiated cells. These distant effects are called bystander effects when occurring at short distance (<1 mm), and systemic effects when occurring at much longer distance. Systemic effects implicate the immune system. These findings showed that cells can die without receiving any radiation dose, and that a more complex and integrated view of radiobiology is required. This includes the notion that the direct, bystander and systemic responses cannot be dissociated because DNA damage is intimately linked to bystander effects and immune response. Here, we provide a brief overview of the paradigms that need to be revisited.
- 3Canter, B. S.; Leung, C. N.; Christopher Fritton, J.; Bäck, T.; Rajon, D.; Azzam, E. I.; Howell, R. W. Radium-223-Induced Bystander Effects Cause DNA Damage and Apoptosis in Disseminated Tumor Cells in Bone Marrow. Mol. Cancer Res. 2021, 19, 1739– 1750, DOI: 10.1158/1541-7786.MCR-21-0005Google ScholarThere is no corresponding record for this reference.
- 4Tafreshi, N. K.; Doligalski, M. L.; Tichacek, C. J.; Pandya, D. N.; Budzevich, M. M.; El-Haddad, G.; Khushalani, N. I.; Moros, E. G.; McLaughlin, M. L.; Wadas, T. J.; Morse, D. L. Development of Targeted Alpha Particle Therapy for Solid Tumors. Molecules 2019, 24, 4314, DOI: 10.3390/molecules24234314Google Scholar4https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitl2rs7%252FL&md5=ac1622ac521eb7fa196e9264dec7593aDevelopment of targeted alpha particle therapy for solid tumorsTafreshi, Narges K.; Doligalski, Michael L.; Tichacek, Christopher J.; Pandya, Darpan N.; Budzevich, Mikalai M.; El-Haddad, Ghassan; Khushalani, Nikhil I.; Moros, Eduardo G.; McLaughlin, Mark L.; Wadas, Thaddeus J.; Morse, David L.Molecules (2019), 24 (23), 4314CODEN: MOLEFW; ISSN:1420-3049. (MDPI AG)Targeted alpha-particle therapy (TAT) aims to selectively deliver radionuclides emitting α-particles (cytotoxic payload) to tumors by chelation to monoclonal antibodies, peptides or small mols. that recognize tumor-assocd. antigens or cell-surface receptors. Because of the high linear energy transfer (LET) and short range of alpha (α) particles in tissue, cancer cells can be significantly damaged while causing minimal toxicity to surrounding healthy cells. Recent clin. studies have demonstrated the remarkable efficacy of TAT in the treatment of metastatic, castration-resistant prostate cancer. In this comprehensive review, we discuss the current consensus regarding the properties of the α-particle-emitting radionuclides that are potentially relevant for use in the clinic; the TAT-mediated mechanisms responsible for cell death; the different classes of targeting moieties and radiometal chelators available for TAT development; current approaches to calcg. radiation dosimetry for TATs; and lead optimization via medicinal chem. to improve the TAT radiopharmaceutical properties. We have also summarized the use of TATs in pre-clin. and clin. studies to date.
- 5Ballangrud, Å. M.; Yang, W. H.; Palm, S.; Enmon, R.; Borchardt, P. E.; Pellegrini, V. A.; McDevitt, M. R.; Scheinberg, D. A.; Sgouros, G. Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer SpheroidsEfficacy versus HER2/Neu Expression. Clin. Cancer Res. 2004, 10, 4489– 4497, DOI: 10.1158/1078-0432.CCR-03-0800Google Scholar5https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVWlurw%253D&md5=1847bbc433b1c3c3105cc938a57fc804Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids: Efficacy versus HER2/neu ExpressionBallangrud, Ase M.; Yang, Wei-Hong; Palm, Stig; Enmon, Richard; Borchardt, Paul E.; Pellegrini, Virginia A.; McDevitt, Michael R.; Scheinberg, David A.; Sgouros, GeorgeClinical Cancer Research (2004), 10 (13), 4489-4497CODEN: CCREF4; ISSN:1078-0432. (American Association for Cancer Research)PURPOSE: The humanized monoclonal antibody, trastuzumab (Herceptin), directed against HER2/neu, has been effective in the treatment of breast cancer malignancies. However, clin. activity has depended on HER2/neu expression. Radiolabeled trastuzumab has been considered previously as a potential agent for radioimmunotherapy. The objective of this study was to investigate the efficacy of trastuzumab labeled with the α-particle emitting at. generator, actinium-225 (225Ac), against breast cancer spheroids with different HER2/neu expression levels. 225Ac has a 10-day half-life and a decay scheme yielding four α-particles. Exptl. Design: The breast carcinoma cell lines MCF7, MDA-MB-361 (MDA), and BT-474 (BT) with relative HER2/neu expression (by flow cytometry) of 1:4:18 were used. Spheroids of these cell lines were incubated with different concns. of 225Ac-trastuzumab, and spheroid growth was measured by light microscopy over a 50-day period. RESULTS: The activity concn. required to yield a 50% redn. in spheroid vol. at day 35 was 18.1, 1.9, and 0.6 kBq/mL (490, 52, 14 nCi/mL) for MCF7, MDA, and BT spheroids, resp. MCF7 spheroids continued growing but with a 20-30 day growth delay at 18.5 kBq/mL. MDA spheroid growth was delayed by 30-40 days at 3.7 kBq/mL; at 18.5 kBq/mL, 12 of 12 spheroids disaggregated after 70, days and cells remaining from each spheroid failed to form colonies within 2 wk of being transferred to adherent dishes. Eight of 10 BT spheroids failed to regrow at 1.85 kBq/mL. All of the BT spheroids at activity concns. 3.7 kBq/mL failed to regrow and to form colonies. The radiosensitivity of these three lines as spheroids was evaluated as the activity concn. required to reduce the treated to untreated spheroid vol. ratio to 0.37, denoted DVR37. An external beam radiosensitivity of 2 Gy was found for spheroids of all three of the cell lines. After α-particle irradn. a DVR37 of 1.5, 3.0, and 2.0 kBq/mL was detd. for MCF7, MDA, and BT, resp. CONCLUSION: These studies suggest that 225Ac-labeled trastuzumab may be a potent therapeutic agent against metastatic breast cancer cells exhibiting intermediate to high HER2/neu expression.
- 6Allen, B. J.; Huang, C.-Y.; Clarke, R. A. Targeted Alpha Anticancer Therapies: Update and Future Prospects. Biol. Targets Ther. 2014, 8, 255– 267, DOI: 10.2147/BTT.S29947Google ScholarThere is no corresponding record for this reference.
- 7Feuerecker, B.; Biechl, P.; Seidl, C.; Bruchertseifer, F.; Morgenstern, A.; Schwaiger, M.; Eisenreich, W. Diverse Metabolic Response of Cancer Cells Treated with a 213 Bi-Anti-EGFR-Immunoconjugate. Sci. Rep. 2021, 11, 6227, DOI: 10.1038/s41598-021-84421-4Google ScholarThere is no corresponding record for this reference.
- 8Song, H.; Hobbs, R. F.; Vajravelu, R.; Huso, D. L.; Esaias, C.; Apostolidis, C.; Morgenstern, A.; Sgouros, G. Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213 Bi and 90Y. Cancer Res. 2009, 69, 8941– 8948, DOI: 10.1158/0008-5472.CAN-09-1828Google ScholarThere is no corresponding record for this reference.
- 9Eychenne, R.; Chérel, M.; Haddad, F.; Guérard, F.; Gestin, J. F. Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight.. Pharmaceutics 2021, 13, 906, DOI: 10.3390/pharmaceutics13060906Google Scholar9https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXislahurvL&md5=98644e63adc302df59a06f4b3e4b9ff5Overview of the most promising radionuclides for targeted alpha therapy: the "hopeful eight"Eychenne, Romain; Cherel, Michel; Haddad, Ferid; Guerard, Francois; Gestin, Jean-FrancoisPharmaceutics (2021), 13 (6), 906CODEN: PHARK5; ISSN:1999-4923. (MDPI AG)Among all existing radionuclides, only a few are of interest for therapeutic applications and more specifically for targeted alpha therapy (TAT). From this selection, actinium-225, astatine-211, bismuth-212, bismuth-213, lead-212, radium-223, terbium-149 and thorium-227 are considered as the most suitable. Despite common general features, they all have their own phys. characteristics that make them singular and so promising for TAT. These radionuclides were largely studied over the last two decades, leading to a better knowledge of their prodn. process and chem. behavior, allowing for an increasing no. of biol. evaluations. The aim of this review is to summarize the main properties of these eight chosen radionuclides. An overview from their availability to the resulting clin. studies, by way of chem. design and preclin. studies is discussed.
- 10de Kruijff, R. M.; Wolterbeek, H. T.; Denkova, A. G. A Critical Review of Alpha Radionuclide Therapy─How to Deal with Recoiling Daughters?. Pharmaceuticals 2015, 8, 321– 336, DOI: 10.3390/ph8020321Google Scholar10https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKmt7vN&md5=0944931e1addfe7277e48e6a7d2e5529A critical review of alpha radionuclide therapy-how to deal with recoiling daughters?de Kruijff, Robin M.; Wolterbeek, Hubert T.; Denkova, Antonia G.Pharmaceuticals (2015), 8 (2), 321-336CODEN: PHARH2; ISSN:1424-8247. (MDPI AG)This review presents an overview of the successes and challenges currently faced in alpha radionuclide therapy. Alpha particles have an advantage in killing tumor cells as compared to beta or gamma radiation due to their short penetration depth and high linear energy transfer (LET). Touching briefly on the clin. successes of radionuclides emitting only one alpha particle, the main focus of this article lies on those alpha-emitting radionuclides with multiple alpha-emitting daughters in their decay chain. While having the advantage of longer half-lives, the recoiled daughters of radionuclides like 224Ra (radium), 223Ra, and 225Ac (actinium) can do significant damage to healthy tissue when not retained at the tumor site. Three different approaches to deal with this problem are discussed: encapsulation in a nano-carrier, fast uptake of the alpha emitting radionuclides in tumor cells, and local administration. Each approach has been shown to have its advantages and disadvantages, but when larger activities need to be used clin., nano-carriers appear to be the most promising soln. for reducing toxic effects, provided there is no accumulation in healthy tissue.
- 11Merkx, R. I. J.; Rijpkema, M.; Franssen, G. M.; Kip, A.; Smeets, B.; Morgenstern, A.; Bruchertseifer, F.; Yan, E.; Wheatcroft, M. P.; Oosterwijk, E.; Mulders, P. F. A.; Heskamp, S. Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model. Pharmaceuticals 2022, 15, 570, DOI: 10.3390/ph15050570Google ScholarThere is no corresponding record for this reference.
- 12Membreno, R.; Cook, B. E.; Zeglis, B. M. Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction. J. Vis. Exp. 2019, 2019, 59041 DOI: 10.3791/59041Google ScholarThere is no corresponding record for this reference.
- 13Toro-González, M.; Dame, A. N.; Mirzadeh, S.; Rojas, J. V. Gadolinium Vanadate Nanocrystals as Carriers of α-Emitters (225Ac, 227Th) and Contrast Agents. J. Appl. Phys. 2019, 125, 214901 DOI: 10.1063/1.5096880Google Scholar13https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsVSmsLg%253D&md5=bbff63403a5332b47d1a34c1f79927f6Gadolinium vanadate nanocrystals as carriers of α-emitters (225Ac, 227Th) and contrast agentsToro-Gonzalez, Miguel; Dame, Ashley N.; Mirzadeh, Saed; Rojas, Jessika V.Journal of Applied Physics (Melville, NY, United States) (2019), 125 (21), 214901/1-214901/11CODEN: JAPIAU; ISSN:0021-8979. (American Institute of Physics)Gadolinium vanadate (GdVO4) core and core + 2 shell nanocrystals (NCs) were evaluated for in vitro retention of 225Ac, 227Th, and their first decay daughters, 221Fr and 223Ra, resp. GdVO4 NCs with a tetragonal crystal system (zircon-type) and spherical morphol. were obtained by pptn. of GdCl3 and Na3VO4 using sodium citrate as a complexing agent. The growth of two nonradioactive GdVO4 shells on both Gd(225Ac)VO4 and Gd(227Th)VO4 core NCs was demonstrated by an increase of 0.7 nm and 2 nm in the crystallite size, resp. The max. leakage of 225Ac was 15% and 2.4% from core and core + 2 shells, whereas the leakage of 227Th was 3% and 1.5%, resp. The presence of two nonradioactive GdVO4 shells increased the retention of 221Fr and 223Ra by 20% and 15% with respect to core NCs. Furthermore, a longitudinal proton relaxivity, r1 = 0.9289 s-1 mM-1, confirmed their potential application as contrast agents for magnetic resonance imaging. In summary, GdVO4 NCs show promising capabilities as radionuclide carriers with partial retention of decay daughters and as contrast agents for theranostic applications. (c) 2019 American Institute of Physics.
- 14Toro-González, M.; Dame, A. N.; Mirzadeh, S.; Rojas, J. V. Encapsulation and Retention of 225Ac, 223Ra, 227Th, and Decay Daughters in Zircon-Type Gadolinium Vanadate Nanoparticles. Radiochim. Acta 2020, 108, 967– 977, DOI: 10.1515/ract-2019-3206Google ScholarThere is no corresponding record for this reference.
- 15Tao, Y.; Sun, Y.; Shi, K.; Pei, P.; Ge, F.; Yang, K.; Liu, T. Versatile Labeling of Multiple Radionuclides onto a Nanoscale Metal–Organic Framework for Tumor Imaging and Radioisotope Therapy. Biomater. Sci. 2021, 9, 2947– 2954, DOI: 10.1039/D0BM02225JGoogle ScholarThere is no corresponding record for this reference.
- 16Tanahashi, K.; Mikos, A. G. Effect of Hydrophilicity and Agmatine Modification on Degradation of Poly(Propylene Fumarate-Co-Ethylene Glycol) Hydrogels. J. Biomed. Mater. Res. Part A 2003, 67A, 1148– 1154, DOI: 10.1002/jbm.a.10147Google ScholarThere is no corresponding record for this reference.
- 17Sanità, G.; Carrese, B.; Lamberti, A. Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization. Front. Mol. Biosci. 2020, 7, 587012 DOI: 10.3389/fmolb.2020.587012Google Scholar17https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXlsVWrt70%253D&md5=5e755a3fc0e201e5e8f92c317e3145b6Nanoparticle surface functionalization: how to improve biocompatibility and cellular internalizationSanita, Gennaro; Carrese, Barbara; Lamberti, AnnalisaFrontiers in Molecular Biosciences (2020), 7 (), 587012CODEN: FMBRBS; ISSN:2296-889X. (Frontiers Media S.A.)A review. The use of nanoparticles (NP) in diagnosis and treatment of many human diseases, including cancer, is of increasing interest. However, cytotoxic effects of NPs on cells and the uptake efficiency significantly limit their use in clin. practice. The physico-chem. properties of NPs including surface compn., superficial charge, size and shape are considered the key factors that affect the biocompatibility and uptake efficiency of these nanoplatforms. Thanks to the possibility of modifying physico-chem. properties of NPs, it is possible to improve their biocompatibility and uptake efficiency through the functionalization of the NP surface. In this review, we summarize some of the most recent studies in which NP surface modification enhances biocompatibility and uptake. Furthermore, the most used techniques used to assess biocompatibility and uptake are also reported.
- 18VanDyke, D.; Kyriacopulos, P.; Yassini, B.; Wright, A.; Burkhart, E.; Jacek, S.; Pratt, M.; Peterson, C. R.; Rai, P. Nanoparticle Based Combination Treatments for Targeting Multiple Hallmarks of Cancer. Int. J. nano Stud. Technol. 2016, 1– 18, DOI: 10.19070/2167-8685-SI04001Google ScholarThere is no corresponding record for this reference.
- 19Woodward, J.; Kennel, S. J.; Stuckey, A.; Osborne, D.; Wall, J.; Rondinone, A. J.; Standaert, R. F.; Mirzadeh, S. LaPO4 Nanoparticles Doped with Actinium-225 That Partially Sequester Daughter Radionuclides. Bioconjugate Chem. 2011, 22, 766– 776, DOI: 10.1021/bc100574fGoogle Scholar19https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslequrs%253D&md5=3363850f2b36cb26208da90af63df9ccLaPO4 Nanoparticles Doped with Actinium-225 that Partially Sequester Daughter RadionuclidesWoodward, Jonathan; Kennel, Stephen J.; Stuckey, Alan; Osborne, Dustin; Wall, Jonathan; Rondinone, Adam J.; Standaert, Robert F.; Mirzadeh, SaedBioconjugate Chemistry (2011), 22 (4), 766-776CODEN: BCCHES; ISSN:1043-1802. (American Chemical Society)Nanoscale materials have been envisioned as carriers for various therapeutic drugs, including radioisotopes. Inorg. nanoparticles (NPs) are particularly appealing vehicles for targeted radiotherapy because they can package several radioactive atoms into a single carrier and can potentially retain daughter radioisotopes produced by in vivo generators such as actinium-225 (225Ac, t1/2 = 10 d). Decay of this radioisotope to stable bismuth-209 proceeds through a chain of short-lived daughters accompanied by the emission of four α-particles that release >27 MeV of energy. The challenge in realizing the enhanced cytotoxic potential of in vivo generators lies in retaining the daughter nuclei at the therapy site. When 225Ac is attached to targeting agents via std. chelate conjugation methods, all of the daughter radionuclides are released after the initial α-decay occurs. In this work, 225Ac was incorporated into lanthanum phosphate NPs to det. whether the radioisotope and its daughters would be retained within the dense mineral lattice. Further, the 225Ac-doped NPs were conjugated to the monoclonal antibody mAb 201B, which targets mouse lung endothelium through the vasculature, to ascertain the targeting efficacy and in vivo retention of radioisotopes. Std. biodistribution techniques and microSPECT/CT imaging of 225Ac as well as the daughter radioisotopes showed that the NPs accumulated rapidly in mouse lung after i.v. injection. By showing that excess, competing, uncoupled antibodies or NPs coupled to control mAbs are deposited primarily in the liver and spleen, specific targeting of NP-mAb 201B conjugates was demonstrated. Biodistribution anal. showed that ∼ 30% of the total injected dose of La(225Ac)PO4 NPs accumulated in mouse lungs 1 h postinjection, yielding a value of % ID/g >200. Furthermore, after 24 h, 80% of the 213Bi daughter produced from 225Ac decay was retained within the target organ and 213Bi retention increased to ∼ 87% at 120 h. In vitro analyses, conducted over a 1 mo interval, demonstrated that ∼ 50% of the daughters were retained within the La(225Ac)PO4 NPs at any point over that time frame. Although most of the γ-rays from radionuclides in the 225Ac decay chain are too energetic to be captured efficiently by SPECT detectors, appropriate energy windows were found that provided dramatic microSPECT images of the NP distribution in vivo. We conclude that La(225Ac)PO4-mAb 201B conjugates can be targeted efficiently to mouse lung while partially retaining daughter products and that targeting can be monitored by biodistribution techniques and microSPECT imaging.
- 20Rojas, J. V.; Woodward, J. D.; Chen, N.; Rondinone, A. J.; Castano, C. H.; Mirzadeh, S. Synthesis and Characterization of Lanthanum Phosphate Nanoparticles as Carriers for 223Ra and 225Ra for Targeted Alpha Therapy. Nucl. Med. Biol. 2015, 42, 614– 620, DOI: 10.1016/j.nucmedbio.2015.03.007Google ScholarThere is no corresponding record for this reference.
- 21McLaughlin, M. F.; Woodward, J.; Boll, R. A.; Rondinone, A. J.; Mirzadeh, S.; Robertson, J. D. Gold-Coated Lanthanide Phosphate Nanoparticles for an 225Ac in Vivo Alpha Generator. Radiochim. Acta 2013, 101, 595– 600, DOI: 10.1524/ract.2013.2066Google Scholar21https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1Srt7w%253D&md5=19a713ed11834c7d7b9712c86a26f7f9Gold-coated lanthanide phosphate nanoparticles for an 225Ac in vivo alpha generatorMcLaughlin, M. F.; Woodward, J.; Boll, R. A.; Rondinone, A. J.; Mirzadeh, S.; Robertson, J. D.Radiochimica Acta (2013), 101 (9), 595-600CODEN: RAACAP; ISSN:0033-8230. (Oldenbourg Wissenschaftsverlag GmbH)Retaining radioactive daughter products at a clin. relevant target site remains one of the major challenges in development of in vivo α generators with radionuclides such as 225Ac and 223Ra. In this work, we examine the ability of layered nanoparticle constructs to retain 225Ac and the first decay daughter, 221Fr. Actinium-225 is cocrystalized in a lanthanide phosphate nanoparticle consisting of varying amts. of La and Gd. Addnl. lanthanide phosphate layers improve retention capability while an outer layer of gold facilitates the attachment of targeting moieties for in vivo use. Retention of 225Ac in the nanoparticles is near quant. while the 221Fr retention varies from 60-89% as a function of time, the no. of layers, and nanoparticle compn. Decay cor. radiochem. yield in the multi-shell syntheses are high (76%) and comparable to or better than existing delivery approaches.
- 22Toro-González, M.; Peacock, A.; Miskowiec, A.; Cullen, D. A.; Copping, R.; Mirzadeh, S.; Davern, S. M. Tailoring the Radionuclide Encapsulation and Surface Chemistry of La(223Ra)VO4 Nanoparticles for Targeted Alpha Therapy. J. Nanotheranostics 2021, 2, 33– 50, DOI: 10.3390/jnt2010003Google ScholarThere is no corresponding record for this reference.
- 23Toro-González, M.; Dame, A. N.; Foster, C. M.; Millet, L. J.; Woodward, J. D.; Rojas, J. V.; Mirzadeh, S.; Davern, S. M. Quantitative Encapsulation and Retention of 227Th and Decay Daughters in Core–Shell Lanthanum Phosphate Nanoparticles. Nanoscale 2020, 12, 9744– 9755, DOI: 10.1039/D0NR01172JGoogle ScholarThere is no corresponding record for this reference.
- 24Toro-González, M.; Copping, R.; Mirzadeh, S.; Rojas, J. V. Multifunctional GdVO4:Eu Core–Shell Nanoparticles Containing 225Ac for Targeted Alpha Therapy and Molecular Imaging. J. Mater. Chem. B 2018, 6, 7985– 7997, DOI: 10.1039/C8TB02173BGoogle ScholarThere is no corresponding record for this reference.
- 25Kanematsu, N.; Inaniwa, T.; Koba, Y. Relationship between Electron Density and Effective Densities of Body Tissues for Stopping, Scattering, and Nuclear Interactions of Proton and Ion Beams. Med. Phys. 2012, 39, 1016– 1020, DOI: 10.1118/1.3679339Google ScholarThere is no corresponding record for this reference.
- 26Greaves, G.; Hinks, J. A.; Busby, P.; Mellors, N. J.; Ilinov, A.; Kuronen, A.; Nordlund, K.; Donnelly, S. E. Enhanced Sputtering Yields from Single-Ion Impacts on Gold Nanorods. Phys. Rev. Lett. 2013, 111, 065504 DOI: 10.1103/PhysRevLett.111.065504Google ScholarThere is no corresponding record for this reference.
- 27Holzwarth, U.; Ojea Jimenez, I.; Calzolai, L. A Random Walk Approach to Estimate the Confinement of α-Particle Emitters in Nanoparticles for Targeted Radionuclide Therapy. EJNMMI Radiopharm. Chem. 2018, 3, 9, DOI: 10.1186/s41181-018-0042-3Google ScholarThere is no corresponding record for this reference.
- 28Thijssen, L.; Schaart, D. R.; De Vries, D.; Morgenstern, A.; Bruchertseifer, F.; Denkova, A. G. Polymersomes as Nano-Carriers to Retain Harmful Recoil Nuclides in Alpha Radionuclide Therapy: A Feasibility Study. Radiochim. Acta 2012, 100, 473– 481, DOI: 10.1524/ract.2012.1935Google ScholarThere is no corresponding record for this reference.
- 29de Kruijff, R. M.; Drost, K.; Thijssen, L.; Morgenstern, A.; Bruchertseifer, F.; Lathouwers, D.; Wolterbeek, H. T.; Denkova, A. G. Improved 225Ac Daughter Retention in InPO4 Containing Polymersomes. Appl. Radiat. Isot. 2017, 128, 183– 189, DOI: 10.1016/j.apradiso.2017.07.030Google Scholar29https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Sjs7%252FP&md5=7c6032506e55774dc641a24fae02e3f8Improved 225Ac daughter retention in InPO4 containing polymersomesde Kruijff, R. M.; Drost, K.; Thijssen, L.; Morgenstern, A.; Bruchertseifer, F.; Lathouwers, D.; Wolterbeek, H. T.; Denkova, A. G.Applied Radiation and Isotopes (2017), 128 (), 183-189CODEN: ARISEF; ISSN:0969-8043. (Elsevier Ltd.)Alpha-emitting radionuclides like actinium-225 (225Ac) are ideal candidates for the treatment of small metastasised tumors, where the long half-life of 225Ac enables it to also reach less accessible tumors. The main challenge lies in retaining the recoiled alpha-emitting daughter nuclides, which are decoupled from targeting agents upon emission of an alpha particle and can subsequently cause unwanted toxicity to healthy tissue. Polymersomes, vesicles composed of amphiphilic block copolymers, are capable of transporting (radio)pharmaceuticals to tumors, and are ideal candidates for the retention of these daughter nuclides. In this study, the Geant4 Monte Carlo simulation package was used to simulate ideal vesicle designs. Vesicles contg. an InPO4 nanoparticle in the core were found to have the highest recoil retention, and were subsequently synthesized in the lab. The recoil retention of two of the daughter nuclides, namely francium-221 (221Fr) and bismuth-213 (213Bi) was detd. at different vesicle sizes. Recoil retention was found to have improved significantly, from 37 ± 4% and 22 ± 1% to 57 ± 5% and 40 ± 2% for 221Fr and 213Bi resp. for 100 nm polymersomes, as compared to earlier published results by Wang et al. where 225Ac was encapsulated using a hydrophilic chelate (Wang et al. 2014). To better understand the different parameters influencing daughter retention, simulation data was expanded to include vesicle polydispersity and nanoparticle position within the polymersome. The high retention of the recoiling daughters and the 225Ac itself makes this vesicle design very suitable for future in vivo verification.
- 30Gangwar, P.; Pandey, M.; Sivakumar, S.; Pala, R. G. S.; Parthasarathy, G. Increased Loading of Eu3+ Ions in Monazite LaVO4 Nanocrystals via Pressure-Driven Phase Transitions. Cryst. Growth Des. 2013, 13, 2344– 2349, DOI: 10.1021/cg3018908Google Scholar30https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslansb4%253D&md5=1558ee06d4828f13d09a6788a94d5e26Increased Loading of Eu3+ Ions in Monazite LaVO4 Nanocrystals via Pressure-Driven Phase TransitionsGangwar, Pooja; Pandey, Mohnish; Sivakumar, Sri; Pala, Raj Ganesh S.; Parthasarathy, G.Crystal Growth & Design (2013), 13 (6), 2344-2349CODEN: CGDEFU; ISSN:1528-7483. (American Chemical Society)The concn. of Eu3+ ion/dopant in the LaVO4 monazite nanocrystal phase cannot be increased by the conventional synthetic procedures. The authors demonstrate a unique 3-step methodol. to increase the doping concn. of Eu3+ in the LaVO4 monazite nanocrystals. In the 1st step, Eu3+ is doped (10%) in the zircon LaVO4 nanocrystal phase, which does not have a limitation in terms of Eu3+ ion loading. In the 2nd step, high pressure (∼5 GPa) is used to transform the zircon crystal phase to the monazite phase. In the 3rd step, the pressure is brought back to the atm. level, wherein the monazite crystal phase is retained in its metastable phase with the 10% Eu3+ ion doping concn. The phase transitions were characterized via elec. resistivity data, XRD, Raman spectroscopy, fluorescence spectroscopy, TEM, and d. functional simulations.
- 31Jia, C. N.; Sun, L. D.; Yan, Z. G.; Pang, Y. C.; Lü, S. Z.; Yan, C. H. Monazite and Zircon Type LaVO4:Eu Nanocrystals – Synthesis, Luminescent Properties, and Spectroscopic Identification of the Eu3+ Sites. Eur. J. Inorg. Chem. 2010, 2010, 2626– 2635, DOI: 10.1002/ejic.201000038Google ScholarThere is no corresponding record for this reference.
- 32Nuñez, N. O.; Zambrano, P.; García-Sevillano, J.; Cantelar, E.; Rivera-Fernández, S.; De La Fuente, J. M.; Ocaña, M. Uniform Poly(Acrylic Acid)-Functionalized Lanthanide-Doped LaVO4 Nanophosphors with High Colloidal Stability and Biocompatibility. Eur. J. Inorg. Chem. 2015, 2015, 4546– 4554, DOI: 10.1002/ejic.201500265Google ScholarThere is no corresponding record for this reference.
- 33Cheng, X.; Guo, D.; Feng, S.; Yang, K.; Wang, Y.; Ren, Y.; Song, Y. Structure and Stability of Monazite- and Zircon-Type LaVO4 under Hydrostatic Pressure. Opt. Mater. (Amst). 2015, 49, 32– 38, DOI: 10.1016/j.optmat.2015.08.011Google ScholarThere is no corresponding record for this reference.
- 34Oka, Y.; Yao, T.; Yamamoto, N. Hydrothermal Synthesis of Lanthanum Vanadates: Synthesis and Crystal Structures of Zircon-Type LaVO4 and a New Compound LaV3O9. J. Solid State Chem. 2000, 152, 486– 491, DOI: 10.1006/jssc.2000.8717Google Scholar34https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVKrtbk%253D&md5=7788f815642abc6e3c16775baf13e984Hydrothermal Synthesis of Lanthanum Vanadates: Synthesis and Crystal Structures of Zircon-Type LaVO4 and a New Compound LaV3O9Oka, Yoshio; Yao, Takeshi; Yamamoto, NaoichiJournal of Solid State Chemistry (2000), 152 (2), 486-491CODEN: JSSCBI; ISSN:0022-4596. (Academic Press)In the hydrothermal synthesis of lanthanum vanadates, zircon-type LaVO4 and LaV3O9 were obtained and structurally characterized. The former is a metastable phase, and the latter is a new compd. Single-crystal x-ray diffractometry confirmed the zircon-type structure for LaVO4: space group I41/amd with a 7.4578(7), c 6.5417(9) Å, and Z = 4; R = 0.020 and Rw = 0.025 for 276 reflections with I > 3σ(I). The structure consists of isolated VO4 tetrahedra which surround the La atom to form a LaO8 dodecahedron. LaV3O9 adopts the monoclinic system: space group P21/m with a 4.949(2), b 9.547(3), c 7.411(2) Å, β 100.76(2)°, and Z = 2; R = 0.035 and Rw = 0.042 for 1868 reflections with I > 3σ(I). The structure adopts a chain-type one consisting of a V3O9 chain along [010] which is made up of edge-sharing VO5 trigonal-bipyramid pairs and VO4 tetrahedra. The La atom residues between the V3O9 chains and is coordinated with ten oxygens. The present study demonstrates the applicability of hydrothermal method to the synthesis of new and/or metastable lanthanide vanadates. (c) 2000 Academic Press.
- 35Ropp, R. C.; Carroll, B. Precipitation of Rare Earth Vanadates from Aqueous Solution. J. Inorg. Nucl. Chem. 1977, 39, 1303– 1307, DOI: 10.1016/0022-1902(77)80286-8Google Scholar35https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXivVCrsQ%253D%253D&md5=dad055ae5790f9c0435fbf4d3be488eaPrecipitation of rare earth vanadates from aqueous solutionRopp, R. C.; Carroll, B.Journal of Inorganic and Nuclear Chemistry (1977), 39 (8), 1303-7CODEN: JINCAO; ISSN:0022-1902.The chem. of V in soln. was studied over the entire pH range by titrating acidic solns. of VO2+ and La3+ or Y3+ with mixed solns. of base and oxidizing agent to ppt. insol. La and Y vanadates. VO2+ was oxidized early in the titrn. to VO2+ which then condensed in soln. to form the anionic vanadate ppts. Using this method, the problem of the instability range at pH 5.5-7.5 caused by pptn. of hydrous V2O5 was avoided.
- 36Xu, Z.; Li, C.; Hou, Z.; Peng, C.; Lin, J. Morphological Control and Luminescence Properties of Lanthanide Orthovanadate LnVO4 (Ln = La to Lu) Nano-/Microcrystals Viahydrothermal Process. CrystEngComm 2011, 13, 474– 482, DOI: 10.1039/C0CE00161AGoogle ScholarThere is no corresponding record for this reference.
- 37Lotfi, S.; El Ouardi, M.; Ait Ahsaine, H.; Madigou, V.; BaQais, A.; Assani, A.; Saadi, M.; Arab, M. Low-Temperature Synthesis, Characterization and Photocatalytic Properties of Lanthanum Vanadate LaVO4. Heliyon 2023, 9, e17255 DOI: 10.1016/j.heliyon.2023.e17255Google ScholarThere is no corresponding record for this reference.
- 38Zhong, J.; Zhao, W. Novel Dumbbell-like LaVO4:Eu3+ Nanocrystals and Effect of Ba2+ Codoping on Luminescence Properties of LaVO4:Eu3+ Nanocrystals. J. Sol-Gel Sci. Technol. 2015, 73, 133– 140, DOI: 10.1007/s10971-014-3504-4Google ScholarThere is no corresponding record for this reference.
- 39Tian, L.; Mho, S. Enhanced Photoluminescence of YVO4:Eu3+ by Codoping the Sr2+, Ba2+ or Pb2+ Ion. J. Lumin. 2007, 122–123, 99– 103, DOI: 10.1016/j.jlumin.2006.01.108Google ScholarThere is no corresponding record for this reference.
- 40Huignard, A.; Gacoin, T.; Boilot, J. P. Synthesis and Luminescence Properties of Colloidal YVO4:Eu Phosphors. Chem. Mater. 2000, 12, 1090– 1094, DOI: 10.1021/cm990722tGoogle Scholar40https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFymsrw%253D&md5=f7ac4db1f9081f7fc8c6f8eefdce4963Synthesis and Luminescence Properties of Colloidal YVO4:Eu PhosphorsHuignard, Arnaud; Gacoin, Thierry; Boilot, Jean-PierreChemistry of Materials (2000), 12 (4), 1090-1094CODEN: CMATEX; ISSN:0897-4756. (American Chemical Society)Concd. colloidal solns. of well-dispersed YVO4:Eu nanoparticles are synthesized by pptn. reactions at room temp. and stabilized by Na hexametaphosphate. x-ray diffraction and electron microscopy characterizations show that the cryst. nanoparticles exhibit an ellipsoidal form with 2 characteristic dimensions of ∼15 and 30 nm. In comparison with the bulk, a lower luminescence efficiency as well as a higher concn. quenching are obsd. These deviations are explained as the variations of some characteristics of the colloidal samples, such as the crystallinity and the surface chem. When these parameters are optimized, the quantum yield of the luminescence reaches 38% for the nanoparticles contg. a Eu concn. of 15%.
- 41Deblonde, G. J. P.; Zavarin, M.; Kersting, A. B. The Coordination Properties and Ionic Radius of Actinium: A 120-Year-Old Enigma. Coord. Chem. Rev. 2021, 446, 214130 DOI: 10.1016/j.ccr.2021.214130Google Scholar41https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXhs1eju7nI&md5=9794394454135ab2b8e4cf074a663940The coordination properties and ionic radius of actinium: A 120-year-old enigmaDeblonde, Gauthier J.-P.; Zavarin, Mavrik; Kersting, Annie B.Coordination Chemistry Reviews (2021), 446 (), 214130CODEN: CCHRAM; ISSN:0010-8545. (Elsevier B.V.)A review. Actinium is an elusive element with untamed properties and represents a peculiar case in the periodic table, as its isotopes are all radioactive, the longest-lived one having only a 22-yr half-life, and the availability of actinium isotopes remains very low (microgram level, at best), hindering research on its compds. Despite being a natural element discovered more than 120 years ago, and despite an increasing interest in using one of its isotopes (225Ac) for highly efficient cancer therapies, the chem. of actinium is still largely unknown relative to other elements. Since Ac is the first element of the actinide series, it is accepted that its ion, Ac3+, is the most voluminous trivalent cation of the periodic table. However, the structural data available on Ac3+ compds. are scarce and have mainly been collected in the 1940-1960's, when actinide chem. was still in its infancy, and have not been put in perspective with the advances in the chem. of other elements, making it difficult to accurately evaluate its actual size and coordination chem. Herein, we review progress made on the chem. of lanthanides and actinides and reevaluate the structural data published on Ac3+ since the era of the Manhattan Project. The data are combined across different spectroscopic and characterization methods and presented in the context of periodic trends. When considering crystallog. data, soln. chem. results, and the nuclear properties of actinium isotopes, it appears that some structural parameters ascribed to the Ac3+ ion may have been overestimated. This review can guide researchers interested in actinide sciences and those who are pursuing the development of actinium-based radiotherapies, from isotope prodn. to clin. trials.
- 42Su, J.; Mi, X.; Sun, J.; Yang, L.; Hui, C.; Lu, L.; Bai, Z.; Zhang, X. Tunable Luminescence and Energy Transfer Properties in YVO4:Bi3+, Eu3+ Phosphors. J. Mater. Sci. 2017, 52, 782– 792, DOI: 10.1007/s10853-016-0375-9Google Scholar42https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2rtLbE&md5=7f8473175121a71468fe639ef0372040Tunable luminescence and energy transfer properties in YVO4:Bi3+, Eu3+ phosphorsSu, Jiangang; Mi, Xiaoyun; Sun, Jiacheng; Yang, Lixin; Hui, Chunlong; Lu, Liping; Bai, Zhaohui; Zhang, XiyanJournal of Materials Science (2017), 52 (2), 782-792CODEN: JMTSAS; ISSN:0022-2461. (Springer)In this paper, YVO4:Bi3+, Eu3+ phosphors have been synthesized by high-temp. solid-state method. The samples were characterized by X-ray powder diffraction, photoluminescence spectra, luminescence lifetime, and GSAS structure refinement. The excitation spectrum of YVO4:Bi3+, Eu3+ monitoring at 622 nm was a broad band with major peak located at 280 nm. It contained the charge transfer from 2p orbit of O2- to 4f orbit of Eu3+ (257 nm) and the absorbing from energy level transition of Bi3+ (1S0→3P1, 346 nm) and VO43- (lA1→1T2, 286 nm and lA1→1T1, 320 nm) through gauss fitting. Upon excitation at a wavelength of 280 nm, the major emission peak of YVO4:Bi3+, Eu3+ located at 622 nm (red) was attributed to the elec. dipole transition 5D0→7F2 of Eu3+. The energy transfer mechanism of Bi3+→Eu3+ was also studied to be dipole-quadrupole mechanism of elec. multipole interaction, and the crit. distance between Eu3+ and Bi3+ was calcd. by concn. quenching method. The emission color of YVO4:Bi3+, Eu3+ can be tuned by the energy transfer of ions and the concn. of activator. In a word, the material has a good application prospects in the field of light-emitting diode under UV excitation.
- 43Rapp, M.; Lozano, Y.; Fernández-Ramos, M.; Isasi, J.; Palafox, M. A. Superparamagnetic and Light-Emitting Bifunctional Nanocomposites of Iron Oxide and Erbium or Thulium Doped Yttrium Orthovanadate. J. Alloys Compd. 2022, 929, 167065 DOI: 10.1016/j.jallcom.2022.167065Google ScholarThere is no corresponding record for this reference.
- 44Yang, L.; Li, G.; Hu, W.; Zhao, M.; Sun, L.; Zheng, J.; Yan, T.; Li, L. Control Over the Crystallinity and Defect Chemistry of YVO4 Nanocrystals for Optimum Photocatalytic Property. Eur. J. Inorg. Chem. 2011, 2011, 2211– 2220, DOI: 10.1002/ejic.201001341Google ScholarThere is no corresponding record for this reference.
- 45Wang, F.; Yu, L.; Zhu, Y.; Zhu, Z.; Meng, X.; Lv, Y.; Peng, S.; Yang, L. Defect Control and Optical Performance of Yttrium Orthovanadate Nanocrystals via a Facile PH-Sensitive Synthesis. J. Alloys Compd. 2023, 968, 172259 DOI: 10.1016/j.jallcom.2023.172259Google ScholarThere is no corresponding record for this reference.
- 46Ling-Hu, P.; Guo, X.; Hu, J.; Deng, C.; Cui, R. Anomalous 5D0→7F4 Transition of Eu3+-Doped BaLaGaO4 Phosphors for WLEDs and Plant Growth Applications. Adv. Opt. Mater. 2024, 12, 2301760 DOI: 10.1002/adom.202301760Google ScholarThere is no corresponding record for this reference.
- 47Chi, F.; Wei, X.; Zhou, S.; Chen, Y.; Duan, C.; Yin, M. Enhanced 5D0 → 7F4 Transition and Optical Thermometry of Garnet Type Ca3Ga2Ge3O12:Eu3+ Phosphors. Inorg. Chem. Front. 2018, 5, 1288– 1293, DOI: 10.1039/C8QI00199EGoogle Scholar47https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVyiur8%253D&md5=bf5da1dbc209f8832f523c219ec4e46fEnhanced 5D0 → 7F4 transition and optical thermometry of garnet type Ca3Ga2Ge3O12:Eu3+ phosphorsChi, Fengfeng; Wei, Xiantao; Zhou, Shaoshuai; Chen, Yonghu; Duan, Changkui; Yin, MinInorganic Chemistry Frontiers (2018), 5 (6), 1288-1293CODEN: ICFNAW; ISSN:2052-1553. (Royal Society of Chemistry)The garnet type phosphors of Eu3+ doped Ca3Ga2Ge3O12 were synthesized via conventional solid state reaction techniques. The phase purity and luminescence properties of the fabricated phosphors were characterized by X-ray powder diffraction, photoluminescence excitation and emission spectra, temp. dependent emission spectra as well as luminescence decay curves. The phosphors show enhanced red emission from a 5D0 → 7F4 transition of Eu3+ under the excitation of 394 nm. The unusual 5D0 → 7F4 intensity was explained by structural anal. The emission intensity of the phosphors increases with the concn. of Eu3+ until the quenching concn. of 10 mol%. Excited by a pulsed laser of wavelength 610.8 nm, the emission intensity of the 5D0 → 7F4 transition increases monotonously as the temp. increases in the range of 160-360 K. The temp. dependent fluorescence behavior was investigated. The relative sensitivity reaches the max. value of 3.66% K-1 at 160 K and reaches 1.04% K-1 at 300 K. The results show that the garnet type Ca3Ga2Ge3O12:Eu3+ phosphor is a promising material for the application of optical thermometry.
- 48Shannon, R. D. Revised Effective Ionic Radii and Systematic Studies of Interatomic Distances in Halides and Chalcogenides. Acta Crystallogr., Sect. A 1976, 32, 751– 767, DOI: 10.1107/S0567739476001551Google ScholarThere is no corresponding record for this reference.
- 49Severin, A. V.; Vasiliev, A. N.; Gopin, A. V.; Vlasova, I. E.; Chernykh, E. V. Dynamics of Sorption─Desorption of 223Ra Therapeutic α-Emitter on Granulated Hydroxyapatite. Radiochemistry 2019, 61, 339– 346, DOI: 10.1134/S1066362219030093Google ScholarThere is no corresponding record for this reference.
- 50Kozempel, J.; Vlk, M.; Málková, E.; Bajzíková, A.; Bárta, J.; Santos-Oliveira, R.; Malta Rossi, A. Prospective Carriers of 223Ra for Targeted Alpha Particle Therapy. J. Radioanal. Nucl. Chem. 2015, 304, 443– 447, DOI: 10.1007/s10967-014-3615-yGoogle ScholarThere is no corresponding record for this reference.
- 51Suchánková, P.; Kukleva, E.; Nykl, E.; Nykl, P.; Sakmár, M.; Vlk, M.; Kozempel, J. Hydroxyapatite and Titanium Dioxide Nanoparticles: Radiolabelling and In Vitro Stability of Prospective Theranostic Nanocarriers for 223Ra and 99mTc. Nanomater. 2020, 10, 1632, DOI: 10.3390/nano10091632Google ScholarThere is no corresponding record for this reference.
- 52Suchánková, P.; Kukleva, E.; Štamberg, K.; Nykl, P.; Sakmár, M.; Vlk, M.; Kozempel, J. Determination, Modeling and Evaluation of Kinetics of 223Ra Sorption on Hydroxyapatite and Titanium Dioxide Nanoparticles. Mater. 2020, 13, 1915, DOI: 10.3390/ma13081915Google ScholarThere is no corresponding record for this reference.
- 53Kukleva, E.; Suchánková, P.; Štamberg, K.; Vlk, M.; Šlouf, M.; Kozempel, J. Surface Protolytic Property Characterization of Hydroxyapatite and Titanium Dioxide Nanoparticles. RSC Adv. 2019, 9, 21989– 21995, DOI: 10.1039/C9RA03698AGoogle ScholarThere is no corresponding record for this reference.
- 54Suchánková, P.; Kukleva, E.; Štamberg, K.; Nykl, P.; Vlk, M.; Kozempel, J. Study of 223Ra Uptake Mechanism on Hydroxyapatite and Titanium Dioxide Nanoparticles as a Function of PH. RSC Adv. 2020, 10, 3659– 3666, DOI: 10.1039/C9RA08953EGoogle ScholarThere is no corresponding record for this reference.
- 55Muckley, E. S.; Aytug, T.; Mayes, R.; Lupini, A. R.; Carrillo, J. M. Y.; Goswami, M.; Sumpter, B. G.; Ivanov, I. N. Hierarchical TiO2:Cu2O Nanostructures for Gas/Vapor Sensing and CO2 Sequestration. ACS Appl. Mater. Interfaces 2019, 11, 48466– 48475, DOI: 10.1021/acsami.9b18824Google Scholar55https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1WktrjE&md5=ef2c524a25efd6729fd78cce3aaabbdcHierarchical TiO2:Cu2O Nanostructures for Gas/Vapor Sensing and CO2 SequestrationMuckley, Eric S.; Aytug, Tolga; Mayes, Richard; Lupini, Andrew R.; Carrillo, Jan-Michael Y.; Goswami, Monojoy; Sumpter, Bobby G.; Ivanov, Ilia N.ACS Applied Materials & Interfaces (2019), 11 (51), 48466-48475CODEN: AAMICK; ISSN:1944-8244. (American Chemical Society)We investigate the effect of high-surface-area self-assembled TiO2:Cu2O nanostructures for CO2 and relative humidity (RH) gravimetric detection using polyethylenimine (PEI), 1-ethyl-3-methylimidazolium (EMIM), and polyacrylamide (PAAm). Introduction of hierarchical TiO2:Cu2O nanostructures on the surface of quartz crystal microbalance (QCM) sensors is found to significantly improve sensitivity to CO2 and to H2O vapor. The response of EMIM to CO2 increases 5-fold for 100 nm thick TiO2:Cu2O as compared to gold. At ambient CO2 concns. the hierarchical assembly operates as a sensor with excellent reversibility, while at higher pressures the CO2 desorption rate decreases, suggesting possible application for CO2 sequestration under those conditions. The gravimetric response of PEI to CO2 increases by a factor of 3 upon introduction of a 50 nm TiO2:Cu2O layer. The PAAm gravimetric response to water vapor also increases by a factor of 3 and displays improved reversibility with the addn. of 50 nm TiO2:Cu2O structures. We found that TiO2:Cu2O can be used to lower the detection limits for CO22 sensing with EMIM and PEI and lower detection limits for H2O sensing with RAAm by over a factor of two. Coarse-grained and all-atom mol. dynamics simulations indicate the dissociative character of ionic liq. assembly on TiO2:Cu2O interfaces and different distributions of CO2 and H2O mols. on bare and ionic liq.-coated surfaces, confirming exptl. observations. Overall, our results show high potential of hierarchical assemblies of TiO2:Cu2O / room temp. ionic liq. and polymer films for sensors and CO2 sequestration.
- 56White, F. D.; Thiele, N. A.; Simms, M. E.; Cary, S. K. Structure and Bonding of a Radium Coordination Compound in the Solid State. Nat. Chem. 2024, 16, 168– 172, DOI: 10.1038/s41557-023-01366-zGoogle ScholarThere is no corresponding record for this reference.
- 57Akamo, D. O.; Kumar, N.; Li, Y.; Pekol, C.; Li, K.; Goswami, M.; Hirschey, J.; LaClair, T. J.; Keffer, D. J.; Rios, O.; Gluesenkamp, K. R. Stabilization of Low-Cost Phase Change Materials for Thermal Energy Storage Applications. iScience 2023, 26, 107175 DOI: 10.1016/j.isci.2023.107175Google ScholarThere is no corresponding record for this reference.
- 58Vives, S.; Ramel, D.; Meunier, C. Evolution of the Structure with the Composition and the Defect Arrangement in the Gadolinium and Samarium Doped and Co-Doped Ceria Systems: A Molecular Dynamics Study. Solid State Ionics 2021, 364, 115611 DOI: 10.1016/j.ssi.2021.115611Google ScholarThere is no corresponding record for this reference.
- 59Li, P.; Merz, K. M. Metal Ion Modeling Using Classical Mechanics. Chem. Rev. 2017, 117, 1564– 1686, DOI: 10.1021/acs.chemrev.6b00440Google Scholar59https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVSg&md5=1cd2a84bd580b3b4e3493bfdd4bc4da1Metal Ion Modeling Using Classical MechanicsLi, Pengfei; Merz, Kenneth M., Jr.Chemical Reviews (Washington, DC, United States) (2017), 117 (3), 1564-1686CODEN: CHREAY; ISSN:0009-2665. (American Chemical Society)A review. Metal ions play significant roles in numerous fields including chem., geochem., biochem. and materials science. With computational tools increasingly becoming important in chem. research, methods have emerged to effectively face the challenge of modeling metal ions in the gas, aq. and solid phases. Herein we review both quantum and classical modeling strategies for metal ion contg. systems that have been developed over the past few decades. This review focuses on classical metal ion modeling based on unpolarized models (including the nonbonded, bonded, cationic dummy atom, and combined models), polarizable models (e.g., the fluctuating charge, Drude oscillator, and the induced dipole models), the angular overlap model, and valence bond based models. Quantum mech. studies of metal ion contg. systems at the semiempirical, ab initio and d. functional levels of theory are reviewed as well with a particular focus on how these methods inform classical modeling efforts. Finally, conclusions and future prospects and directions are offered that will further enhance the classical modeling of metal ion contg. systems.
- 60Boll, R. A.; Malkemus, D.; Mirzadeh, S. Production of Actinium-225 for Alpha Particle Mediated Radioimmunotherapy. Appl. Radiat. Isot. 2005, 62, 667– 679, DOI: 10.1016/j.apradiso.2004.12.003Google Scholar60https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitFajs7o%253D&md5=e25a534e723a7796e5fc60c2fb21888dProduction of actinium-225 for alpha particle mediated radioimmunotherapyBoll, Rose A.; Malkemus, Dairin; Mirzadeh, SaedApplied Radiation and Isotopes (2005), 62 (5), 667-679CODEN: ARISEF; ISSN:0969-8043. (Elsevier B.V.)The initial clin. trials for treatment of acute myeloid leukemia demonstrated the effectiveness of the alpha emitter 213Bi in killing cancer cells. Bi-213 is obtained from a radionuclide generator system from decay of 10-days 225Ac parent. Recent pre-clin. studies also showed the potential application of both 213Bi, and the 225Ac parent radionuclide in a variety of cancer systems and targeted radiotherapy. This paper describes the 5 years of experience in prodn. of 225Ac in partial support of the on-going clin. trials. A 4-step chem. process, consisting of both anion and cation exchange chromatog., is used for routine sepn. of carrier-free 225Ac from a mixt. of 228Th, 229Th and 232Th. The sepn. of Ra and Ac from Th is achieved using the macroporous anion exchange resin MP1 in 8 M HNO3 media. Two sequential MP1/NO3 columns provide a sepn. factor of ∼106 for Ra and Ac from Th. The sepn. of Ac from Ra is accomplished on a low crosslinking cation exchange resin AG50-X4 using 1.2M HNO3 as eluant. Two sequential AG50/NO3 columns provide a sepn. factor of ∼102 for Ac from Ra. A 60-day processing schedule was adopted to reduce the processing cost and to provide the highest levels of 225Ac possible. Over an 8-wk campaign, a total of ∼100 mCi of 225Ac (∼80% of the theor. yield) is shipped in 5-6 batches, with the 1st batch typically consisting of ∼50 mCi. After the initial sepn. and purifn. of Ac, the Ra pool is re-processed on a bi-weekly schedule or as needed to provide smaller batches of 225Ac. The averaged radioisotopic purity of the 225Ac was 99.6 ± 0.7% with a 225Ra content of ≤0.6%, and an av. 229Th content of (4+5-4)×10-5%.
- 61Huignard, A.; Buissette, V.; Laurent, G.; Gacoin, T.; Boilot, J. P. Synthesis and Characterizations of YVO4: Eu Colloids. Chem. Mater. 2002, 14, 2264– 2269, DOI: 10.1021/cm011263aGoogle Scholar61https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVarurY%253D&md5=571c98983852a8e5ddeb654056e97f3fSynthesis and Characterizations of YVO4:Eu ColloidsHuignard, A.; Buissette, V.; Laurent, G.; Gacoin, T.; Boilot, J. P.Chemistry of Materials (2002), 14 (5), 2264-2269CODEN: CMATEX; ISSN:0897-4756. (American Chemical Society)A new process for the synthesis of colloidal Eu-doped YVO4 with a particle diam. of ∼10 nm is presented. Nanocrystals are produced by pptn. of citrate complexes of rare earth salts with Na3VO4. NMR and IR studies show that the interaction between citrate ligands and lanthanide ions limits the growth of particles and ensures the stability of the colloidal solns. through electrostatic and steric repulsions. The optimized process leads to stable and highly concd. transparent colloidal solns. in H2O (≤400 g/L).
- 62Young, R. A.. The Rietveld Method; Oxford University Press, 1981.Google ScholarThere is no corresponding record for this reference.
- 63Toby, B. H.; Von Dreele, R. B. GSAS-II: The Genesis of a Modern Open-Source All Purpose Crystallography Software Package. J. Appl. Crystallogr. 2013, 46, 544– 549, DOI: 10.1107/S0021889813003531Google Scholar63https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFWnu7c%253D&md5=48a7dcdb1d1f10d6f9d7fe3e746d58fdGSAS-II: the genesis of a modern open-source all purpose crystallography software packageToby, Brian H.; Von Dreele, Robert B.Journal of Applied Crystallography (2013), 46 (2), 544-549CODEN: JACGAR; ISSN:0021-8898. (International Union of Crystallography)The newly developed GSAS-II software is a general purpose package for data redn., structure soln. and structure refinement that can be used with both single-crystal and powder diffraction data from both neutron and x-ray sources, including lab. and synchrotron sources, collected on both two- and 1-dimensional detectors. It is intended that GSAS-II will eventually replace both the GSAS and the EXPGUI packages, as well as many other utilities. GSAS-II is open source and is written largely in object-oriented Python but offers speeds comparable to compiled code because of its reliance on the Python NumPy and SciPy packages for computation. It runs on all common computer platforms and offers highly integrated graphics, both for a user interface and for interpretation of parameters. The package can be applied to all stages of crystallog. anal. for const.-wavelength x-ray and neutron data. Plans for considerable addnl. development are discussed.
- 64Thompson, A. P.; Aktulga, H. M.; Berger, R.; Bolintineanu, D. S.; Brown, W. M.; Crozier, P. S.; in’t Veld, P. J.; Kohlmeyer, A.; Moore, S. G.; Nguyen, T. D.; Shan, R.; Stevens, M. J.; Tranchida, J.; Trott, C.; Plimpton, S. J. LAMMPS - a Flexible Simulation Tool for Particle-Based Materials Modeling at the Atomic, Meso, and Continuum Scales. Comput. Phys. Commun. 2022, 271, 108171 DOI: 10.1016/j.cpc.2021.108171Google Scholar64https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXitlSrsb7O&md5=cd0bfd050820e97c11779003add20ed3LAMMPS - a flexible simulation tool for particle-based materials modeling at the atomic, meso, and continuum scalesThompson, Aidan P.; Aktulga, H. Metin; Berger, Richard; Bolintineanu, Dan S.; Brown, W. Michael; Crozier, Paul S.; in 't Veld, Pieter J.; Kohlmeyer, Axel; Moore, Stan G.; Nguyen, Trung Dac; Shan, Ray; Stevens, Mark J.; Tranchida, Julien; Trott, Christian; Plimpton, Steven J.Computer Physics Communications (2022), 271 (), 108171CODEN: CPHCBZ; ISSN:0010-4655. (Elsevier B.V.)Since the classical mol. dynamics simulator LAMMPS was released as an open source code in 2004, it has become a widely-used tool for particle-based modeling of materials at length scales ranging from at. to mesoscale to continuum. Reasons for its popularity are that it provides a wide variety of particle interaction models for different materials, that it runs on any platform from a single CPU core to the largest supercomputers with accelerators, and that it gives users control over simulation details, either via the input script or by adding code for new interat. potentials, constraints, diagnostics, or other features needed for their models. As a result, hundreds of people have contributed new capabilities to LAMMPS and it has grown from fifty thousand lines of code in 2004 to a million lines today. In this paper several of the fundamental algorithms used in LAMMPS are described along with the design strategies which have made it flexible for both users and developers. We also highlight some capabilities recently added to the code which were enabled by this flexibility, including dynamic load balancing, on-the-fly visualization, magnetic spin dynamics models, and quantum-accuracy machine learning interat. potentials.Program Title: Large-scale Atomic/Mol. Massively Parallel Simulator (LAMMPS)CPC Library link to program files:https://doi.org/10.17632/cxbxs9btsv.1Developer's repository link:https://github.com/lammps/lammpsLicensing provisions: GPLv2Programming language: C++, Python, C, FortranSupplementary material:https://www.lammps.orgNature of problem: Many science applications in physics, chem., materials science, and related fields require parallel, scalable, and efficient generation of long, stable classical particle dynamics trajectories. Within this common problem definition, there lies a great diversity of use cases, distinguished by different particle interaction models, external constraints, as well as timescales and lengthscales ranging from at. to mesoscale to macroscopic.Soln. method: The LAMMPS code uses parallel spatial decompn., distributed neighbor lists, and parallel FFTs for long-range Coulombic interactions [1]. The time integration algorithm is based on the Stormer-Verlet symplectic integrator [2], which provides better stability than higher-order non-symplectic methods. In addn., LAMMPS supports a wide range of interat. potentials, constraints, diagnostics, software interfaces, and pre- and post-processing features.Addnl. comments including restrictions and unusual features: This paper serves as the definitive ref. for the LAMMPS code.S. Plimpton, Fast parallel algorithms for short-range mol. dynamics. Phys. 117 (1995) 1-19.L. Verlet, Computer expts. on classical fluids: I. Thermodynamical properties of Lennard-Jones mols., Phys. Rev. 159 (1967) 98-103.
- 65Martinez, L.; Andrade, R.; Birgin, E. G.; Martínez, J. M. PACKMOL: A Package for Building Initial Configurations for Molecular Dynamics Simulations. J. Comput. Chem. 2009, 30, 2157– 2164, DOI: 10.1002/jcc.21224Google Scholar65https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptleqsb8%253D&md5=2a76255c873b866a26540f7e84496272PACKMOL: A package for building initial configurations for molecular dynamics simulationsMartinez, L.; Andrade, R.; Birgin, E. G.; Martinez, J. M.Journal of Computational Chemistry (2009), 30 (13), 2157-2164CODEN: JCCHDD; ISSN:0192-8651. (John Wiley & Sons, Inc.)Adequate initial configurations for mol. dynamics simulations consist of arrangements of mols. distributed in space in such a way to approx. represent the system's overall structure. In order that the simulations are not disrupted by large van der Waals repulsive interactions, atoms from different mols. must keep safe pairwise distances. Obtaining such a mol. arrangement can be considered a packing problem: Each type mol. must satisfy spatial constraints related to the geometry of the system, and the distance between atoms of different mols. must be greater than some specified tolerance. We have developed a code able to pack millions of atoms, grouped in arbitrarily complex mols., inside a variety of three-dimensional regions. The regions may be intersections of spheres, ellipses, cylinders, planes, or boxes. The user must provide only the structure of one mol. of each type and the geometrical constraints that each type of mol. must satisfy. Building complex mixts., interfaces, solvating biomols. in water, other solvents, or mixts. of solvents, is straightforward. In addn., different atoms belonging to the same mol. may also be restricted to different spatial regions, in such a way that more ordered mol. arrangements can be built, as micelles, lipid double-layers, etc. The packing time for state-of-the-art mol. dynamics systems varies from a few seconds to a few minutes in a personal computer. The input files are simple and currently compatible with PDB, Tinker, Molden, or Moldy coordinate files. The package is distributed as free software and can be downloaded from . © 2009 Wiley Periodicals, Inc. J Comput Chem, 2009.
- 66Qiao, B.; Skanthakumar, S.; Soderholm, L. Comparative CHARMM and AMOEBA Simulations of Lanthanide Hydration Energetics and Experimental Aqueous-Solution Structures. J. Chem. Theory Comput. 2018, 14, 1781– 1790, DOI: 10.1021/acs.jctc.7b01018Google Scholar66https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1Ojs7o%253D&md5=4584c2953f83d9c9d8dc894503df8d98Comparative CHARMM and AMOEBA Simulations of Lanthanide Hydration Energetics and Experimental Aqueous-Solution StructuresQiao, Baofu; Skanthakumar, S.; Soderholm, L.Journal of Chemical Theory and Computation (2018), 14 (3), 1781-1790CODEN: JCTCCE; ISSN:1549-9618. (American Chemical Society)The accurate understanding of metal ion hydration in solns. is a prerequisite for predicting stability, reactivity, and soly. Herein, additive CHARMM force field parameters were developed to enable mol. dynamics simulations of lanthanide (Ln) speciation in water. Quant. similar to the much more resource-intensive polarizable AMOEBA potential, the CHARMM simulations reproduce the exptl. hydration free energies and correlations in the first shell (Ln-oxygen distance and hydration no.). Comparisons of difference pair-distribution functions obtained from the two simulation approaches with those from high-energy x-ray scattering expts. reveal good agreement of first-coordination sphere correlations for the Lu3+ ion (CHARMM only), but further improvement to both approaches is required to reproduce the broad, non-Gaussian distribution seen from the La3+ expt. Second-coordination sphere comparisons demonstrate the importance of explicitly including an anion in the simulation. This work describes the usefulness of less resource-intensive additive potentials in some complex chem. systems such as soln. environments where multiple interactions have similar energetics. In addn., 3-dimensional descriptions of the La3+ and Lu3+ coordination geometries are extd. from the CHARMM simulations and generally discussed in terms of potential improvements to solute-structure modeling within soln. environments.
- 67Priest, C.; Zhou, J.; Jiang, D.; en Solvation of the Vanadate Ion in Seawater Conditions from Molecular Dynamics Simulations. Inorg. Chim. Acta 2017, 458, 39– 44, DOI: 10.1016/j.ica.2016.12.027Google Scholar67https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFWqsQ%253D%253D&md5=73b646e8a40212385ebbb517a009c2b4Solvation of the vanadate ion in seawater conditions from molecular dynamics simulationsPriest, Chad; Zhou, Jingwei; Jiang, De-enInorganica Chimica Acta (2017), 458 (), 39-44CODEN: ICHAA3; ISSN:0020-1693. (Elsevier B.V.)One of the current challenges present in uranium extn. from seawater is the competitive sorption of vanadium. But compared with uranium, much less is known about the solvation and speciation of the vanadate ion in seawater. Herein, we utilize both first principles mol. dynamics and classical mol. dynamics simulations to provide a microscopic insight into the solvation of the HVO42- ion in pure water and in seawater. In pure water, we found that the dianion state is the most probable structure. But in a simulated seawater with 0.55 M NaCl, the NaHVO4- ion is most probable, followed by the neutral Na2HVO4; averaging over 100-ns trajectory, the coordination no. of Na+ ions around V was found to be 1.5 within a radius of 4.0 Å. We found that the NaHVO4- ion can exist in two interchangeable states: a bidentate state where the Na+ ion interacts directly with two vanadate oxo groups; a monodentate where the Na+ ion interacts with only one vanadate oxo group. From this monodentate state, the Na+ ion can further dissoc. away with a free-energy barrier of 2.5 kcal/mol. Our work therefore demonstrates that Na+ ions are closely assocd. with the vanadate species in seawater.
- 68Clark, G. N. I.; Cappa, C. D.; Smith, J. D.; Saykally, R. J.; Head-Gordon, T. The Structure of Ambient Water. Mol. Phys. 2010, 108, 1415– 1433, DOI: 10.1080/00268971003762134Google Scholar68https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFylsL4%253D&md5=e87f8ea16df8cad26657f690cf069875The structure of ambient waterClark, Gary N. I.; Cappa, Christopher D.; Smith, Jared D.; Saykally, Richard J.; Head-Gordon, TeresaMolecular Physics (2010), 108 (11), 1415-1433CODEN: MOPHAM; ISSN:0026-8976. (Taylor & Francis Ltd.)We review the spectroscopic techniques and scattering expts. used to probe the structure of water, and their interpretation using empirical and ab initio models, over the last 5 years. We show that all available scientific evidence overwhelmingly favors the view of classifying water near ambient conditions as a uniform, continuous tetrahedral liq. While there are controversial issues in our understanding of water in the supercooled state, in confinement, at interfaces, or in soln., there is no real controversy in what is understood as regards bulk liq. water under ambient conditions.
- 69Goswami, M.; Kumar, N.; Li, Y.; Hirschey, J.; LaClair, T. J.; Akamo, D. O.; Sultan, S.; Rios, O.; Gluesenkamp, K. R.; Graham, S. Understanding Supercooling Mechanism in Sodium Sulfate Decahydrate Phase-Change Material. J. Appl. Phys. 2021, 129, 245109 DOI: 10.1063/5.0049512Google ScholarThere is no corresponding record for this reference.
Cited By
This article has not yet been cited by other publications.
Article Views
Altmetric
Citations
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.
Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.
The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.
Recommended Articles
References
This article references 69 other publications.
- 1Kim, Y. S.; Brechbiel, M. W. An Overview of Targeted Alpha Therapy. Tumor Biol. 2012, 33, 573– 590, DOI: 10.1007/s13277-011-0286-y1https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsF2ntrw%253D&md5=c3688e4aa0b30e5923ba04e1e43bb86eAn overview of targeted alpha therapyKim, Young-Seung; Brechbiel, Martin W.Tumor Biology (2012), 33 (3), 573-590CODEN: TUMBEA; ISSN:1010-4283. (Springer)A review. The effectiveness of targeted α-therapy (TAT) can be explained by the properties of α-particles. Alpha particles are helium nuclei and are ∼8,000 times larger than β--particles (electrons). When emitted from radionuclides that decay via an α-decay pathway, they release enormous amts. of energy over a very short distance. Typically, the range of α-particles in tissue is 50-100 μm and they have high linear energy transfer (LET) with a mean energy deposition of 100 keV/μm, providing a more specific tumor cell killing ability without damage to the surrounding normal tissues than β--emitters. Due to these properties, the majority of pre-clin. and clin. trials have demonstrated that α-emitters such as 225Ac, 211At, 212Bi, 213Bi, 212Pb, 223Ra, and 227Th are ideal for the treatment of smaller tumor burdens, micrometastatic disease, and disseminated disease. Even though these α-emitters have favorable properties, the development of TAT has been limited by high costs, unresolved chem., and limited availability of the radionuclides. To overcome these limitations, more potent isotopes, addnl. sources, and more efficient isotope prodn. methods should be addressed. Furthermore, better chelation and labeling methods with the improvements of isotope delivery, targeting vehicles, mol. targets, and identification of appropriate clin. applications are still required.
- 2Pouget, J. P.; Constanzo, J. Revisiting the Radiobiology of Targeted Alpha Therapy. Front. Med. 2021, 8, 692436 DOI: 10.3389/fmed.2021.6924362https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB2cvktVWntA%253D%253D&md5=c94e3c94e7dc81a867ad3e5d13c9cff0Revisiting the Radiobiology of Targeted Alpha TherapyPouget Jean-Pierre; Constanzo JulieFrontiers in medicine (2021), 8 (), 692436 ISSN:2296-858X.Targeted alpha therapy (TAT) using alpha particle-emitting radionuclides is in the spotlight after the approval of (223)RaCl2 for patients with metastatic castration-resistant prostate cancer and the development of several alpha emitter-based radiopharmaceuticals. It is acknowledged that alpha particles are highly cytotoxic because they produce complex DNA lesions. Hence, the nucleus is considered their critical target, and many studies did not report any effect in other subcellular compartments. Moreover, their physical features, including their range in tissues (<100 μm) and their linear energy transfer (50-230 keV/μm), are well-characterized. Theoretically, TAT is indicated for very small-volume, disseminated tumors (e.g., micrometastases, circulating tumor cells). Moreover, due to their high cytotoxicity, alpha particles should be preferred to beta particles and X-rays to overcome radiation resistance. However, clinical studies showed that TAT might be efficient also in quite large tumors, and biological effects have been observed also away from irradiated cells. These distant effects are called bystander effects when occurring at short distance (<1 mm), and systemic effects when occurring at much longer distance. Systemic effects implicate the immune system. These findings showed that cells can die without receiving any radiation dose, and that a more complex and integrated view of radiobiology is required. This includes the notion that the direct, bystander and systemic responses cannot be dissociated because DNA damage is intimately linked to bystander effects and immune response. Here, we provide a brief overview of the paradigms that need to be revisited.
- 3Canter, B. S.; Leung, C. N.; Christopher Fritton, J.; Bäck, T.; Rajon, D.; Azzam, E. I.; Howell, R. W. Radium-223-Induced Bystander Effects Cause DNA Damage and Apoptosis in Disseminated Tumor Cells in Bone Marrow. Mol. Cancer Res. 2021, 19, 1739– 1750, DOI: 10.1158/1541-7786.MCR-21-0005There is no corresponding record for this reference.
- 4Tafreshi, N. K.; Doligalski, M. L.; Tichacek, C. J.; Pandya, D. N.; Budzevich, M. M.; El-Haddad, G.; Khushalani, N. I.; Moros, E. G.; McLaughlin, M. L.; Wadas, T. J.; Morse, D. L. Development of Targeted Alpha Particle Therapy for Solid Tumors. Molecules 2019, 24, 4314, DOI: 10.3390/molecules242343144https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitl2rs7%252FL&md5=ac1622ac521eb7fa196e9264dec7593aDevelopment of targeted alpha particle therapy for solid tumorsTafreshi, Narges K.; Doligalski, Michael L.; Tichacek, Christopher J.; Pandya, Darpan N.; Budzevich, Mikalai M.; El-Haddad, Ghassan; Khushalani, Nikhil I.; Moros, Eduardo G.; McLaughlin, Mark L.; Wadas, Thaddeus J.; Morse, David L.Molecules (2019), 24 (23), 4314CODEN: MOLEFW; ISSN:1420-3049. (MDPI AG)Targeted alpha-particle therapy (TAT) aims to selectively deliver radionuclides emitting α-particles (cytotoxic payload) to tumors by chelation to monoclonal antibodies, peptides or small mols. that recognize tumor-assocd. antigens or cell-surface receptors. Because of the high linear energy transfer (LET) and short range of alpha (α) particles in tissue, cancer cells can be significantly damaged while causing minimal toxicity to surrounding healthy cells. Recent clin. studies have demonstrated the remarkable efficacy of TAT in the treatment of metastatic, castration-resistant prostate cancer. In this comprehensive review, we discuss the current consensus regarding the properties of the α-particle-emitting radionuclides that are potentially relevant for use in the clinic; the TAT-mediated mechanisms responsible for cell death; the different classes of targeting moieties and radiometal chelators available for TAT development; current approaches to calcg. radiation dosimetry for TATs; and lead optimization via medicinal chem. to improve the TAT radiopharmaceutical properties. We have also summarized the use of TATs in pre-clin. and clin. studies to date.
- 5Ballangrud, Å. M.; Yang, W. H.; Palm, S.; Enmon, R.; Borchardt, P. E.; Pellegrini, V. A.; McDevitt, M. R.; Scheinberg, D. A.; Sgouros, G. Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer SpheroidsEfficacy versus HER2/Neu Expression. Clin. Cancer Res. 2004, 10, 4489– 4497, DOI: 10.1158/1078-0432.CCR-03-08005https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVWlurw%253D&md5=1847bbc433b1c3c3105cc938a57fc804Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids: Efficacy versus HER2/neu ExpressionBallangrud, Ase M.; Yang, Wei-Hong; Palm, Stig; Enmon, Richard; Borchardt, Paul E.; Pellegrini, Virginia A.; McDevitt, Michael R.; Scheinberg, David A.; Sgouros, GeorgeClinical Cancer Research (2004), 10 (13), 4489-4497CODEN: CCREF4; ISSN:1078-0432. (American Association for Cancer Research)PURPOSE: The humanized monoclonal antibody, trastuzumab (Herceptin), directed against HER2/neu, has been effective in the treatment of breast cancer malignancies. However, clin. activity has depended on HER2/neu expression. Radiolabeled trastuzumab has been considered previously as a potential agent for radioimmunotherapy. The objective of this study was to investigate the efficacy of trastuzumab labeled with the α-particle emitting at. generator, actinium-225 (225Ac), against breast cancer spheroids with different HER2/neu expression levels. 225Ac has a 10-day half-life and a decay scheme yielding four α-particles. Exptl. Design: The breast carcinoma cell lines MCF7, MDA-MB-361 (MDA), and BT-474 (BT) with relative HER2/neu expression (by flow cytometry) of 1:4:18 were used. Spheroids of these cell lines were incubated with different concns. of 225Ac-trastuzumab, and spheroid growth was measured by light microscopy over a 50-day period. RESULTS: The activity concn. required to yield a 50% redn. in spheroid vol. at day 35 was 18.1, 1.9, and 0.6 kBq/mL (490, 52, 14 nCi/mL) for MCF7, MDA, and BT spheroids, resp. MCF7 spheroids continued growing but with a 20-30 day growth delay at 18.5 kBq/mL. MDA spheroid growth was delayed by 30-40 days at 3.7 kBq/mL; at 18.5 kBq/mL, 12 of 12 spheroids disaggregated after 70, days and cells remaining from each spheroid failed to form colonies within 2 wk of being transferred to adherent dishes. Eight of 10 BT spheroids failed to regrow at 1.85 kBq/mL. All of the BT spheroids at activity concns. 3.7 kBq/mL failed to regrow and to form colonies. The radiosensitivity of these three lines as spheroids was evaluated as the activity concn. required to reduce the treated to untreated spheroid vol. ratio to 0.37, denoted DVR37. An external beam radiosensitivity of 2 Gy was found for spheroids of all three of the cell lines. After α-particle irradn. a DVR37 of 1.5, 3.0, and 2.0 kBq/mL was detd. for MCF7, MDA, and BT, resp. CONCLUSION: These studies suggest that 225Ac-labeled trastuzumab may be a potent therapeutic agent against metastatic breast cancer cells exhibiting intermediate to high HER2/neu expression.
- 6Allen, B. J.; Huang, C.-Y.; Clarke, R. A. Targeted Alpha Anticancer Therapies: Update and Future Prospects. Biol. Targets Ther. 2014, 8, 255– 267, DOI: 10.2147/BTT.S29947There is no corresponding record for this reference.
- 7Feuerecker, B.; Biechl, P.; Seidl, C.; Bruchertseifer, F.; Morgenstern, A.; Schwaiger, M.; Eisenreich, W. Diverse Metabolic Response of Cancer Cells Treated with a 213 Bi-Anti-EGFR-Immunoconjugate. Sci. Rep. 2021, 11, 6227, DOI: 10.1038/s41598-021-84421-4There is no corresponding record for this reference.
- 8Song, H.; Hobbs, R. F.; Vajravelu, R.; Huso, D. L.; Esaias, C.; Apostolidis, C.; Morgenstern, A.; Sgouros, G. Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213 Bi and 90Y. Cancer Res. 2009, 69, 8941– 8948, DOI: 10.1158/0008-5472.CAN-09-1828There is no corresponding record for this reference.
- 9Eychenne, R.; Chérel, M.; Haddad, F.; Guérard, F.; Gestin, J. F. Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight.. Pharmaceutics 2021, 13, 906, DOI: 10.3390/pharmaceutics130609069https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXislahurvL&md5=98644e63adc302df59a06f4b3e4b9ff5Overview of the most promising radionuclides for targeted alpha therapy: the "hopeful eight"Eychenne, Romain; Cherel, Michel; Haddad, Ferid; Guerard, Francois; Gestin, Jean-FrancoisPharmaceutics (2021), 13 (6), 906CODEN: PHARK5; ISSN:1999-4923. (MDPI AG)Among all existing radionuclides, only a few are of interest for therapeutic applications and more specifically for targeted alpha therapy (TAT). From this selection, actinium-225, astatine-211, bismuth-212, bismuth-213, lead-212, radium-223, terbium-149 and thorium-227 are considered as the most suitable. Despite common general features, they all have their own phys. characteristics that make them singular and so promising for TAT. These radionuclides were largely studied over the last two decades, leading to a better knowledge of their prodn. process and chem. behavior, allowing for an increasing no. of biol. evaluations. The aim of this review is to summarize the main properties of these eight chosen radionuclides. An overview from their availability to the resulting clin. studies, by way of chem. design and preclin. studies is discussed.
- 10de Kruijff, R. M.; Wolterbeek, H. T.; Denkova, A. G. A Critical Review of Alpha Radionuclide Therapy─How to Deal with Recoiling Daughters?. Pharmaceuticals 2015, 8, 321– 336, DOI: 10.3390/ph802032110https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKmt7vN&md5=0944931e1addfe7277e48e6a7d2e5529A critical review of alpha radionuclide therapy-how to deal with recoiling daughters?de Kruijff, Robin M.; Wolterbeek, Hubert T.; Denkova, Antonia G.Pharmaceuticals (2015), 8 (2), 321-336CODEN: PHARH2; ISSN:1424-8247. (MDPI AG)This review presents an overview of the successes and challenges currently faced in alpha radionuclide therapy. Alpha particles have an advantage in killing tumor cells as compared to beta or gamma radiation due to their short penetration depth and high linear energy transfer (LET). Touching briefly on the clin. successes of radionuclides emitting only one alpha particle, the main focus of this article lies on those alpha-emitting radionuclides with multiple alpha-emitting daughters in their decay chain. While having the advantage of longer half-lives, the recoiled daughters of radionuclides like 224Ra (radium), 223Ra, and 225Ac (actinium) can do significant damage to healthy tissue when not retained at the tumor site. Three different approaches to deal with this problem are discussed: encapsulation in a nano-carrier, fast uptake of the alpha emitting radionuclides in tumor cells, and local administration. Each approach has been shown to have its advantages and disadvantages, but when larger activities need to be used clin., nano-carriers appear to be the most promising soln. for reducing toxic effects, provided there is no accumulation in healthy tissue.
- 11Merkx, R. I. J.; Rijpkema, M.; Franssen, G. M.; Kip, A.; Smeets, B.; Morgenstern, A.; Bruchertseifer, F.; Yan, E.; Wheatcroft, M. P.; Oosterwijk, E.; Mulders, P. F. A.; Heskamp, S. Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model. Pharmaceuticals 2022, 15, 570, DOI: 10.3390/ph15050570There is no corresponding record for this reference.
- 12Membreno, R.; Cook, B. E.; Zeglis, B. M. Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction. J. Vis. Exp. 2019, 2019, 59041 DOI: 10.3791/59041There is no corresponding record for this reference.
- 13Toro-González, M.; Dame, A. N.; Mirzadeh, S.; Rojas, J. V. Gadolinium Vanadate Nanocrystals as Carriers of α-Emitters (225Ac, 227Th) and Contrast Agents. J. Appl. Phys. 2019, 125, 214901 DOI: 10.1063/1.509688013https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsVSmsLg%253D&md5=bbff63403a5332b47d1a34c1f79927f6Gadolinium vanadate nanocrystals as carriers of α-emitters (225Ac, 227Th) and contrast agentsToro-Gonzalez, Miguel; Dame, Ashley N.; Mirzadeh, Saed; Rojas, Jessika V.Journal of Applied Physics (Melville, NY, United States) (2019), 125 (21), 214901/1-214901/11CODEN: JAPIAU; ISSN:0021-8979. (American Institute of Physics)Gadolinium vanadate (GdVO4) core and core + 2 shell nanocrystals (NCs) were evaluated for in vitro retention of 225Ac, 227Th, and their first decay daughters, 221Fr and 223Ra, resp. GdVO4 NCs with a tetragonal crystal system (zircon-type) and spherical morphol. were obtained by pptn. of GdCl3 and Na3VO4 using sodium citrate as a complexing agent. The growth of two nonradioactive GdVO4 shells on both Gd(225Ac)VO4 and Gd(227Th)VO4 core NCs was demonstrated by an increase of 0.7 nm and 2 nm in the crystallite size, resp. The max. leakage of 225Ac was 15% and 2.4% from core and core + 2 shells, whereas the leakage of 227Th was 3% and 1.5%, resp. The presence of two nonradioactive GdVO4 shells increased the retention of 221Fr and 223Ra by 20% and 15% with respect to core NCs. Furthermore, a longitudinal proton relaxivity, r1 = 0.9289 s-1 mM-1, confirmed their potential application as contrast agents for magnetic resonance imaging. In summary, GdVO4 NCs show promising capabilities as radionuclide carriers with partial retention of decay daughters and as contrast agents for theranostic applications. (c) 2019 American Institute of Physics.
- 14Toro-González, M.; Dame, A. N.; Mirzadeh, S.; Rojas, J. V. Encapsulation and Retention of 225Ac, 223Ra, 227Th, and Decay Daughters in Zircon-Type Gadolinium Vanadate Nanoparticles. Radiochim. Acta 2020, 108, 967– 977, DOI: 10.1515/ract-2019-3206There is no corresponding record for this reference.
- 15Tao, Y.; Sun, Y.; Shi, K.; Pei, P.; Ge, F.; Yang, K.; Liu, T. Versatile Labeling of Multiple Radionuclides onto a Nanoscale Metal–Organic Framework for Tumor Imaging and Radioisotope Therapy. Biomater. Sci. 2021, 9, 2947– 2954, DOI: 10.1039/D0BM02225JThere is no corresponding record for this reference.
- 16Tanahashi, K.; Mikos, A. G. Effect of Hydrophilicity and Agmatine Modification on Degradation of Poly(Propylene Fumarate-Co-Ethylene Glycol) Hydrogels. J. Biomed. Mater. Res. Part A 2003, 67A, 1148– 1154, DOI: 10.1002/jbm.a.10147There is no corresponding record for this reference.
- 17Sanità, G.; Carrese, B.; Lamberti, A. Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization. Front. Mol. Biosci. 2020, 7, 587012 DOI: 10.3389/fmolb.2020.58701217https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXlsVWrt70%253D&md5=5e755a3fc0e201e5e8f92c317e3145b6Nanoparticle surface functionalization: how to improve biocompatibility and cellular internalizationSanita, Gennaro; Carrese, Barbara; Lamberti, AnnalisaFrontiers in Molecular Biosciences (2020), 7 (), 587012CODEN: FMBRBS; ISSN:2296-889X. (Frontiers Media S.A.)A review. The use of nanoparticles (NP) in diagnosis and treatment of many human diseases, including cancer, is of increasing interest. However, cytotoxic effects of NPs on cells and the uptake efficiency significantly limit their use in clin. practice. The physico-chem. properties of NPs including surface compn., superficial charge, size and shape are considered the key factors that affect the biocompatibility and uptake efficiency of these nanoplatforms. Thanks to the possibility of modifying physico-chem. properties of NPs, it is possible to improve their biocompatibility and uptake efficiency through the functionalization of the NP surface. In this review, we summarize some of the most recent studies in which NP surface modification enhances biocompatibility and uptake. Furthermore, the most used techniques used to assess biocompatibility and uptake are also reported.
- 18VanDyke, D.; Kyriacopulos, P.; Yassini, B.; Wright, A.; Burkhart, E.; Jacek, S.; Pratt, M.; Peterson, C. R.; Rai, P. Nanoparticle Based Combination Treatments for Targeting Multiple Hallmarks of Cancer. Int. J. nano Stud. Technol. 2016, 1– 18, DOI: 10.19070/2167-8685-SI04001There is no corresponding record for this reference.
- 19Woodward, J.; Kennel, S. J.; Stuckey, A.; Osborne, D.; Wall, J.; Rondinone, A. J.; Standaert, R. F.; Mirzadeh, S. LaPO4 Nanoparticles Doped with Actinium-225 That Partially Sequester Daughter Radionuclides. Bioconjugate Chem. 2011, 22, 766– 776, DOI: 10.1021/bc100574f19https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslequrs%253D&md5=3363850f2b36cb26208da90af63df9ccLaPO4 Nanoparticles Doped with Actinium-225 that Partially Sequester Daughter RadionuclidesWoodward, Jonathan; Kennel, Stephen J.; Stuckey, Alan; Osborne, Dustin; Wall, Jonathan; Rondinone, Adam J.; Standaert, Robert F.; Mirzadeh, SaedBioconjugate Chemistry (2011), 22 (4), 766-776CODEN: BCCHES; ISSN:1043-1802. (American Chemical Society)Nanoscale materials have been envisioned as carriers for various therapeutic drugs, including radioisotopes. Inorg. nanoparticles (NPs) are particularly appealing vehicles for targeted radiotherapy because they can package several radioactive atoms into a single carrier and can potentially retain daughter radioisotopes produced by in vivo generators such as actinium-225 (225Ac, t1/2 = 10 d). Decay of this radioisotope to stable bismuth-209 proceeds through a chain of short-lived daughters accompanied by the emission of four α-particles that release >27 MeV of energy. The challenge in realizing the enhanced cytotoxic potential of in vivo generators lies in retaining the daughter nuclei at the therapy site. When 225Ac is attached to targeting agents via std. chelate conjugation methods, all of the daughter radionuclides are released after the initial α-decay occurs. In this work, 225Ac was incorporated into lanthanum phosphate NPs to det. whether the radioisotope and its daughters would be retained within the dense mineral lattice. Further, the 225Ac-doped NPs were conjugated to the monoclonal antibody mAb 201B, which targets mouse lung endothelium through the vasculature, to ascertain the targeting efficacy and in vivo retention of radioisotopes. Std. biodistribution techniques and microSPECT/CT imaging of 225Ac as well as the daughter radioisotopes showed that the NPs accumulated rapidly in mouse lung after i.v. injection. By showing that excess, competing, uncoupled antibodies or NPs coupled to control mAbs are deposited primarily in the liver and spleen, specific targeting of NP-mAb 201B conjugates was demonstrated. Biodistribution anal. showed that ∼ 30% of the total injected dose of La(225Ac)PO4 NPs accumulated in mouse lungs 1 h postinjection, yielding a value of % ID/g >200. Furthermore, after 24 h, 80% of the 213Bi daughter produced from 225Ac decay was retained within the target organ and 213Bi retention increased to ∼ 87% at 120 h. In vitro analyses, conducted over a 1 mo interval, demonstrated that ∼ 50% of the daughters were retained within the La(225Ac)PO4 NPs at any point over that time frame. Although most of the γ-rays from radionuclides in the 225Ac decay chain are too energetic to be captured efficiently by SPECT detectors, appropriate energy windows were found that provided dramatic microSPECT images of the NP distribution in vivo. We conclude that La(225Ac)PO4-mAb 201B conjugates can be targeted efficiently to mouse lung while partially retaining daughter products and that targeting can be monitored by biodistribution techniques and microSPECT imaging.
- 20Rojas, J. V.; Woodward, J. D.; Chen, N.; Rondinone, A. J.; Castano, C. H.; Mirzadeh, S. Synthesis and Characterization of Lanthanum Phosphate Nanoparticles as Carriers for 223Ra and 225Ra for Targeted Alpha Therapy. Nucl. Med. Biol. 2015, 42, 614– 620, DOI: 10.1016/j.nucmedbio.2015.03.007There is no corresponding record for this reference.
- 21McLaughlin, M. F.; Woodward, J.; Boll, R. A.; Rondinone, A. J.; Mirzadeh, S.; Robertson, J. D. Gold-Coated Lanthanide Phosphate Nanoparticles for an 225Ac in Vivo Alpha Generator. Radiochim. Acta 2013, 101, 595– 600, DOI: 10.1524/ract.2013.206621https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1Srt7w%253D&md5=19a713ed11834c7d7b9712c86a26f7f9Gold-coated lanthanide phosphate nanoparticles for an 225Ac in vivo alpha generatorMcLaughlin, M. F.; Woodward, J.; Boll, R. A.; Rondinone, A. J.; Mirzadeh, S.; Robertson, J. D.Radiochimica Acta (2013), 101 (9), 595-600CODEN: RAACAP; ISSN:0033-8230. (Oldenbourg Wissenschaftsverlag GmbH)Retaining radioactive daughter products at a clin. relevant target site remains one of the major challenges in development of in vivo α generators with radionuclides such as 225Ac and 223Ra. In this work, we examine the ability of layered nanoparticle constructs to retain 225Ac and the first decay daughter, 221Fr. Actinium-225 is cocrystalized in a lanthanide phosphate nanoparticle consisting of varying amts. of La and Gd. Addnl. lanthanide phosphate layers improve retention capability while an outer layer of gold facilitates the attachment of targeting moieties for in vivo use. Retention of 225Ac in the nanoparticles is near quant. while the 221Fr retention varies from 60-89% as a function of time, the no. of layers, and nanoparticle compn. Decay cor. radiochem. yield in the multi-shell syntheses are high (76%) and comparable to or better than existing delivery approaches.
- 22Toro-González, M.; Peacock, A.; Miskowiec, A.; Cullen, D. A.; Copping, R.; Mirzadeh, S.; Davern, S. M. Tailoring the Radionuclide Encapsulation and Surface Chemistry of La(223Ra)VO4 Nanoparticles for Targeted Alpha Therapy. J. Nanotheranostics 2021, 2, 33– 50, DOI: 10.3390/jnt2010003There is no corresponding record for this reference.
- 23Toro-González, M.; Dame, A. N.; Foster, C. M.; Millet, L. J.; Woodward, J. D.; Rojas, J. V.; Mirzadeh, S.; Davern, S. M. Quantitative Encapsulation and Retention of 227Th and Decay Daughters in Core–Shell Lanthanum Phosphate Nanoparticles. Nanoscale 2020, 12, 9744– 9755, DOI: 10.1039/D0NR01172JThere is no corresponding record for this reference.
- 24Toro-González, M.; Copping, R.; Mirzadeh, S.; Rojas, J. V. Multifunctional GdVO4:Eu Core–Shell Nanoparticles Containing 225Ac for Targeted Alpha Therapy and Molecular Imaging. J. Mater. Chem. B 2018, 6, 7985– 7997, DOI: 10.1039/C8TB02173BThere is no corresponding record for this reference.
- 25Kanematsu, N.; Inaniwa, T.; Koba, Y. Relationship between Electron Density and Effective Densities of Body Tissues for Stopping, Scattering, and Nuclear Interactions of Proton and Ion Beams. Med. Phys. 2012, 39, 1016– 1020, DOI: 10.1118/1.3679339There is no corresponding record for this reference.
- 26Greaves, G.; Hinks, J. A.; Busby, P.; Mellors, N. J.; Ilinov, A.; Kuronen, A.; Nordlund, K.; Donnelly, S. E. Enhanced Sputtering Yields from Single-Ion Impacts on Gold Nanorods. Phys. Rev. Lett. 2013, 111, 065504 DOI: 10.1103/PhysRevLett.111.065504There is no corresponding record for this reference.
- 27Holzwarth, U.; Ojea Jimenez, I.; Calzolai, L. A Random Walk Approach to Estimate the Confinement of α-Particle Emitters in Nanoparticles for Targeted Radionuclide Therapy. EJNMMI Radiopharm. Chem. 2018, 3, 9, DOI: 10.1186/s41181-018-0042-3There is no corresponding record for this reference.
- 28Thijssen, L.; Schaart, D. R.; De Vries, D.; Morgenstern, A.; Bruchertseifer, F.; Denkova, A. G. Polymersomes as Nano-Carriers to Retain Harmful Recoil Nuclides in Alpha Radionuclide Therapy: A Feasibility Study. Radiochim. Acta 2012, 100, 473– 481, DOI: 10.1524/ract.2012.1935There is no corresponding record for this reference.
- 29de Kruijff, R. M.; Drost, K.; Thijssen, L.; Morgenstern, A.; Bruchertseifer, F.; Lathouwers, D.; Wolterbeek, H. T.; Denkova, A. G. Improved 225Ac Daughter Retention in InPO4 Containing Polymersomes. Appl. Radiat. Isot. 2017, 128, 183– 189, DOI: 10.1016/j.apradiso.2017.07.03029https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Sjs7%252FP&md5=7c6032506e55774dc641a24fae02e3f8Improved 225Ac daughter retention in InPO4 containing polymersomesde Kruijff, R. M.; Drost, K.; Thijssen, L.; Morgenstern, A.; Bruchertseifer, F.; Lathouwers, D.; Wolterbeek, H. T.; Denkova, A. G.Applied Radiation and Isotopes (2017), 128 (), 183-189CODEN: ARISEF; ISSN:0969-8043. (Elsevier Ltd.)Alpha-emitting radionuclides like actinium-225 (225Ac) are ideal candidates for the treatment of small metastasised tumors, where the long half-life of 225Ac enables it to also reach less accessible tumors. The main challenge lies in retaining the recoiled alpha-emitting daughter nuclides, which are decoupled from targeting agents upon emission of an alpha particle and can subsequently cause unwanted toxicity to healthy tissue. Polymersomes, vesicles composed of amphiphilic block copolymers, are capable of transporting (radio)pharmaceuticals to tumors, and are ideal candidates for the retention of these daughter nuclides. In this study, the Geant4 Monte Carlo simulation package was used to simulate ideal vesicle designs. Vesicles contg. an InPO4 nanoparticle in the core were found to have the highest recoil retention, and were subsequently synthesized in the lab. The recoil retention of two of the daughter nuclides, namely francium-221 (221Fr) and bismuth-213 (213Bi) was detd. at different vesicle sizes. Recoil retention was found to have improved significantly, from 37 ± 4% and 22 ± 1% to 57 ± 5% and 40 ± 2% for 221Fr and 213Bi resp. for 100 nm polymersomes, as compared to earlier published results by Wang et al. where 225Ac was encapsulated using a hydrophilic chelate (Wang et al. 2014). To better understand the different parameters influencing daughter retention, simulation data was expanded to include vesicle polydispersity and nanoparticle position within the polymersome. The high retention of the recoiling daughters and the 225Ac itself makes this vesicle design very suitable for future in vivo verification.
- 30Gangwar, P.; Pandey, M.; Sivakumar, S.; Pala, R. G. S.; Parthasarathy, G. Increased Loading of Eu3+ Ions in Monazite LaVO4 Nanocrystals via Pressure-Driven Phase Transitions. Cryst. Growth Des. 2013, 13, 2344– 2349, DOI: 10.1021/cg301890830https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslansb4%253D&md5=1558ee06d4828f13d09a6788a94d5e26Increased Loading of Eu3+ Ions in Monazite LaVO4 Nanocrystals via Pressure-Driven Phase TransitionsGangwar, Pooja; Pandey, Mohnish; Sivakumar, Sri; Pala, Raj Ganesh S.; Parthasarathy, G.Crystal Growth & Design (2013), 13 (6), 2344-2349CODEN: CGDEFU; ISSN:1528-7483. (American Chemical Society)The concn. of Eu3+ ion/dopant in the LaVO4 monazite nanocrystal phase cannot be increased by the conventional synthetic procedures. The authors demonstrate a unique 3-step methodol. to increase the doping concn. of Eu3+ in the LaVO4 monazite nanocrystals. In the 1st step, Eu3+ is doped (10%) in the zircon LaVO4 nanocrystal phase, which does not have a limitation in terms of Eu3+ ion loading. In the 2nd step, high pressure (∼5 GPa) is used to transform the zircon crystal phase to the monazite phase. In the 3rd step, the pressure is brought back to the atm. level, wherein the monazite crystal phase is retained in its metastable phase with the 10% Eu3+ ion doping concn. The phase transitions were characterized via elec. resistivity data, XRD, Raman spectroscopy, fluorescence spectroscopy, TEM, and d. functional simulations.
- 31Jia, C. N.; Sun, L. D.; Yan, Z. G.; Pang, Y. C.; Lü, S. Z.; Yan, C. H. Monazite and Zircon Type LaVO4:Eu Nanocrystals – Synthesis, Luminescent Properties, and Spectroscopic Identification of the Eu3+ Sites. Eur. J. Inorg. Chem. 2010, 2010, 2626– 2635, DOI: 10.1002/ejic.201000038There is no corresponding record for this reference.
- 32Nuñez, N. O.; Zambrano, P.; García-Sevillano, J.; Cantelar, E.; Rivera-Fernández, S.; De La Fuente, J. M.; Ocaña, M. Uniform Poly(Acrylic Acid)-Functionalized Lanthanide-Doped LaVO4 Nanophosphors with High Colloidal Stability and Biocompatibility. Eur. J. Inorg. Chem. 2015, 2015, 4546– 4554, DOI: 10.1002/ejic.201500265There is no corresponding record for this reference.
- 33Cheng, X.; Guo, D.; Feng, S.; Yang, K.; Wang, Y.; Ren, Y.; Song, Y. Structure and Stability of Monazite- and Zircon-Type LaVO4 under Hydrostatic Pressure. Opt. Mater. (Amst). 2015, 49, 32– 38, DOI: 10.1016/j.optmat.2015.08.011There is no corresponding record for this reference.
- 34Oka, Y.; Yao, T.; Yamamoto, N. Hydrothermal Synthesis of Lanthanum Vanadates: Synthesis and Crystal Structures of Zircon-Type LaVO4 and a New Compound LaV3O9. J. Solid State Chem. 2000, 152, 486– 491, DOI: 10.1006/jssc.2000.871734https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVKrtbk%253D&md5=7788f815642abc6e3c16775baf13e984Hydrothermal Synthesis of Lanthanum Vanadates: Synthesis and Crystal Structures of Zircon-Type LaVO4 and a New Compound LaV3O9Oka, Yoshio; Yao, Takeshi; Yamamoto, NaoichiJournal of Solid State Chemistry (2000), 152 (2), 486-491CODEN: JSSCBI; ISSN:0022-4596. (Academic Press)In the hydrothermal synthesis of lanthanum vanadates, zircon-type LaVO4 and LaV3O9 were obtained and structurally characterized. The former is a metastable phase, and the latter is a new compd. Single-crystal x-ray diffractometry confirmed the zircon-type structure for LaVO4: space group I41/amd with a 7.4578(7), c 6.5417(9) Å, and Z = 4; R = 0.020 and Rw = 0.025 for 276 reflections with I > 3σ(I). The structure consists of isolated VO4 tetrahedra which surround the La atom to form a LaO8 dodecahedron. LaV3O9 adopts the monoclinic system: space group P21/m with a 4.949(2), b 9.547(3), c 7.411(2) Å, β 100.76(2)°, and Z = 2; R = 0.035 and Rw = 0.042 for 1868 reflections with I > 3σ(I). The structure adopts a chain-type one consisting of a V3O9 chain along [010] which is made up of edge-sharing VO5 trigonal-bipyramid pairs and VO4 tetrahedra. The La atom residues between the V3O9 chains and is coordinated with ten oxygens. The present study demonstrates the applicability of hydrothermal method to the synthesis of new and/or metastable lanthanide vanadates. (c) 2000 Academic Press.
- 35Ropp, R. C.; Carroll, B. Precipitation of Rare Earth Vanadates from Aqueous Solution. J. Inorg. Nucl. Chem. 1977, 39, 1303– 1307, DOI: 10.1016/0022-1902(77)80286-835https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXivVCrsQ%253D%253D&md5=dad055ae5790f9c0435fbf4d3be488eaPrecipitation of rare earth vanadates from aqueous solutionRopp, R. C.; Carroll, B.Journal of Inorganic and Nuclear Chemistry (1977), 39 (8), 1303-7CODEN: JINCAO; ISSN:0022-1902.The chem. of V in soln. was studied over the entire pH range by titrating acidic solns. of VO2+ and La3+ or Y3+ with mixed solns. of base and oxidizing agent to ppt. insol. La and Y vanadates. VO2+ was oxidized early in the titrn. to VO2+ which then condensed in soln. to form the anionic vanadate ppts. Using this method, the problem of the instability range at pH 5.5-7.5 caused by pptn. of hydrous V2O5 was avoided.
- 36Xu, Z.; Li, C.; Hou, Z.; Peng, C.; Lin, J. Morphological Control and Luminescence Properties of Lanthanide Orthovanadate LnVO4 (Ln = La to Lu) Nano-/Microcrystals Viahydrothermal Process. CrystEngComm 2011, 13, 474– 482, DOI: 10.1039/C0CE00161AThere is no corresponding record for this reference.
- 37Lotfi, S.; El Ouardi, M.; Ait Ahsaine, H.; Madigou, V.; BaQais, A.; Assani, A.; Saadi, M.; Arab, M. Low-Temperature Synthesis, Characterization and Photocatalytic Properties of Lanthanum Vanadate LaVO4. Heliyon 2023, 9, e17255 DOI: 10.1016/j.heliyon.2023.e17255There is no corresponding record for this reference.
- 38Zhong, J.; Zhao, W. Novel Dumbbell-like LaVO4:Eu3+ Nanocrystals and Effect of Ba2+ Codoping on Luminescence Properties of LaVO4:Eu3+ Nanocrystals. J. Sol-Gel Sci. Technol. 2015, 73, 133– 140, DOI: 10.1007/s10971-014-3504-4There is no corresponding record for this reference.
- 39Tian, L.; Mho, S. Enhanced Photoluminescence of YVO4:Eu3+ by Codoping the Sr2+, Ba2+ or Pb2+ Ion. J. Lumin. 2007, 122–123, 99– 103, DOI: 10.1016/j.jlumin.2006.01.108There is no corresponding record for this reference.
- 40Huignard, A.; Gacoin, T.; Boilot, J. P. Synthesis and Luminescence Properties of Colloidal YVO4:Eu Phosphors. Chem. Mater. 2000, 12, 1090– 1094, DOI: 10.1021/cm990722t40https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFymsrw%253D&md5=f7ac4db1f9081f7fc8c6f8eefdce4963Synthesis and Luminescence Properties of Colloidal YVO4:Eu PhosphorsHuignard, Arnaud; Gacoin, Thierry; Boilot, Jean-PierreChemistry of Materials (2000), 12 (4), 1090-1094CODEN: CMATEX; ISSN:0897-4756. (American Chemical Society)Concd. colloidal solns. of well-dispersed YVO4:Eu nanoparticles are synthesized by pptn. reactions at room temp. and stabilized by Na hexametaphosphate. x-ray diffraction and electron microscopy characterizations show that the cryst. nanoparticles exhibit an ellipsoidal form with 2 characteristic dimensions of ∼15 and 30 nm. In comparison with the bulk, a lower luminescence efficiency as well as a higher concn. quenching are obsd. These deviations are explained as the variations of some characteristics of the colloidal samples, such as the crystallinity and the surface chem. When these parameters are optimized, the quantum yield of the luminescence reaches 38% for the nanoparticles contg. a Eu concn. of 15%.
- 41Deblonde, G. J. P.; Zavarin, M.; Kersting, A. B. The Coordination Properties and Ionic Radius of Actinium: A 120-Year-Old Enigma. Coord. Chem. Rev. 2021, 446, 214130 DOI: 10.1016/j.ccr.2021.21413041https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXhs1eju7nI&md5=9794394454135ab2b8e4cf074a663940The coordination properties and ionic radius of actinium: A 120-year-old enigmaDeblonde, Gauthier J.-P.; Zavarin, Mavrik; Kersting, Annie B.Coordination Chemistry Reviews (2021), 446 (), 214130CODEN: CCHRAM; ISSN:0010-8545. (Elsevier B.V.)A review. Actinium is an elusive element with untamed properties and represents a peculiar case in the periodic table, as its isotopes are all radioactive, the longest-lived one having only a 22-yr half-life, and the availability of actinium isotopes remains very low (microgram level, at best), hindering research on its compds. Despite being a natural element discovered more than 120 years ago, and despite an increasing interest in using one of its isotopes (225Ac) for highly efficient cancer therapies, the chem. of actinium is still largely unknown relative to other elements. Since Ac is the first element of the actinide series, it is accepted that its ion, Ac3+, is the most voluminous trivalent cation of the periodic table. However, the structural data available on Ac3+ compds. are scarce and have mainly been collected in the 1940-1960's, when actinide chem. was still in its infancy, and have not been put in perspective with the advances in the chem. of other elements, making it difficult to accurately evaluate its actual size and coordination chem. Herein, we review progress made on the chem. of lanthanides and actinides and reevaluate the structural data published on Ac3+ since the era of the Manhattan Project. The data are combined across different spectroscopic and characterization methods and presented in the context of periodic trends. When considering crystallog. data, soln. chem. results, and the nuclear properties of actinium isotopes, it appears that some structural parameters ascribed to the Ac3+ ion may have been overestimated. This review can guide researchers interested in actinide sciences and those who are pursuing the development of actinium-based radiotherapies, from isotope prodn. to clin. trials.
- 42Su, J.; Mi, X.; Sun, J.; Yang, L.; Hui, C.; Lu, L.; Bai, Z.; Zhang, X. Tunable Luminescence and Energy Transfer Properties in YVO4:Bi3+, Eu3+ Phosphors. J. Mater. Sci. 2017, 52, 782– 792, DOI: 10.1007/s10853-016-0375-942https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2rtLbE&md5=7f8473175121a71468fe639ef0372040Tunable luminescence and energy transfer properties in YVO4:Bi3+, Eu3+ phosphorsSu, Jiangang; Mi, Xiaoyun; Sun, Jiacheng; Yang, Lixin; Hui, Chunlong; Lu, Liping; Bai, Zhaohui; Zhang, XiyanJournal of Materials Science (2017), 52 (2), 782-792CODEN: JMTSAS; ISSN:0022-2461. (Springer)In this paper, YVO4:Bi3+, Eu3+ phosphors have been synthesized by high-temp. solid-state method. The samples were characterized by X-ray powder diffraction, photoluminescence spectra, luminescence lifetime, and GSAS structure refinement. The excitation spectrum of YVO4:Bi3+, Eu3+ monitoring at 622 nm was a broad band with major peak located at 280 nm. It contained the charge transfer from 2p orbit of O2- to 4f orbit of Eu3+ (257 nm) and the absorbing from energy level transition of Bi3+ (1S0→3P1, 346 nm) and VO43- (lA1→1T2, 286 nm and lA1→1T1, 320 nm) through gauss fitting. Upon excitation at a wavelength of 280 nm, the major emission peak of YVO4:Bi3+, Eu3+ located at 622 nm (red) was attributed to the elec. dipole transition 5D0→7F2 of Eu3+. The energy transfer mechanism of Bi3+→Eu3+ was also studied to be dipole-quadrupole mechanism of elec. multipole interaction, and the crit. distance between Eu3+ and Bi3+ was calcd. by concn. quenching method. The emission color of YVO4:Bi3+, Eu3+ can be tuned by the energy transfer of ions and the concn. of activator. In a word, the material has a good application prospects in the field of light-emitting diode under UV excitation.
- 43Rapp, M.; Lozano, Y.; Fernández-Ramos, M.; Isasi, J.; Palafox, M. A. Superparamagnetic and Light-Emitting Bifunctional Nanocomposites of Iron Oxide and Erbium or Thulium Doped Yttrium Orthovanadate. J. Alloys Compd. 2022, 929, 167065 DOI: 10.1016/j.jallcom.2022.167065There is no corresponding record for this reference.
- 44Yang, L.; Li, G.; Hu, W.; Zhao, M.; Sun, L.; Zheng, J.; Yan, T.; Li, L. Control Over the Crystallinity and Defect Chemistry of YVO4 Nanocrystals for Optimum Photocatalytic Property. Eur. J. Inorg. Chem. 2011, 2011, 2211– 2220, DOI: 10.1002/ejic.201001341There is no corresponding record for this reference.
- 45Wang, F.; Yu, L.; Zhu, Y.; Zhu, Z.; Meng, X.; Lv, Y.; Peng, S.; Yang, L. Defect Control and Optical Performance of Yttrium Orthovanadate Nanocrystals via a Facile PH-Sensitive Synthesis. J. Alloys Compd. 2023, 968, 172259 DOI: 10.1016/j.jallcom.2023.172259There is no corresponding record for this reference.
- 46Ling-Hu, P.; Guo, X.; Hu, J.; Deng, C.; Cui, R. Anomalous 5D0→7F4 Transition of Eu3+-Doped BaLaGaO4 Phosphors for WLEDs and Plant Growth Applications. Adv. Opt. Mater. 2024, 12, 2301760 DOI: 10.1002/adom.202301760There is no corresponding record for this reference.
- 47Chi, F.; Wei, X.; Zhou, S.; Chen, Y.; Duan, C.; Yin, M. Enhanced 5D0 → 7F4 Transition and Optical Thermometry of Garnet Type Ca3Ga2Ge3O12:Eu3+ Phosphors. Inorg. Chem. Front. 2018, 5, 1288– 1293, DOI: 10.1039/C8QI00199E47https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVyiur8%253D&md5=bf5da1dbc209f8832f523c219ec4e46fEnhanced 5D0 → 7F4 transition and optical thermometry of garnet type Ca3Ga2Ge3O12:Eu3+ phosphorsChi, Fengfeng; Wei, Xiantao; Zhou, Shaoshuai; Chen, Yonghu; Duan, Changkui; Yin, MinInorganic Chemistry Frontiers (2018), 5 (6), 1288-1293CODEN: ICFNAW; ISSN:2052-1553. (Royal Society of Chemistry)The garnet type phosphors of Eu3+ doped Ca3Ga2Ge3O12 were synthesized via conventional solid state reaction techniques. The phase purity and luminescence properties of the fabricated phosphors were characterized by X-ray powder diffraction, photoluminescence excitation and emission spectra, temp. dependent emission spectra as well as luminescence decay curves. The phosphors show enhanced red emission from a 5D0 → 7F4 transition of Eu3+ under the excitation of 394 nm. The unusual 5D0 → 7F4 intensity was explained by structural anal. The emission intensity of the phosphors increases with the concn. of Eu3+ until the quenching concn. of 10 mol%. Excited by a pulsed laser of wavelength 610.8 nm, the emission intensity of the 5D0 → 7F4 transition increases monotonously as the temp. increases in the range of 160-360 K. The temp. dependent fluorescence behavior was investigated. The relative sensitivity reaches the max. value of 3.66% K-1 at 160 K and reaches 1.04% K-1 at 300 K. The results show that the garnet type Ca3Ga2Ge3O12:Eu3+ phosphor is a promising material for the application of optical thermometry.
- 48Shannon, R. D. Revised Effective Ionic Radii and Systematic Studies of Interatomic Distances in Halides and Chalcogenides. Acta Crystallogr., Sect. A 1976, 32, 751– 767, DOI: 10.1107/S0567739476001551There is no corresponding record for this reference.
- 49Severin, A. V.; Vasiliev, A. N.; Gopin, A. V.; Vlasova, I. E.; Chernykh, E. V. Dynamics of Sorption─Desorption of 223Ra Therapeutic α-Emitter on Granulated Hydroxyapatite. Radiochemistry 2019, 61, 339– 346, DOI: 10.1134/S1066362219030093There is no corresponding record for this reference.
- 50Kozempel, J.; Vlk, M.; Málková, E.; Bajzíková, A.; Bárta, J.; Santos-Oliveira, R.; Malta Rossi, A. Prospective Carriers of 223Ra for Targeted Alpha Particle Therapy. J. Radioanal. Nucl. Chem. 2015, 304, 443– 447, DOI: 10.1007/s10967-014-3615-yThere is no corresponding record for this reference.
- 51Suchánková, P.; Kukleva, E.; Nykl, E.; Nykl, P.; Sakmár, M.; Vlk, M.; Kozempel, J. Hydroxyapatite and Titanium Dioxide Nanoparticles: Radiolabelling and In Vitro Stability of Prospective Theranostic Nanocarriers for 223Ra and 99mTc. Nanomater. 2020, 10, 1632, DOI: 10.3390/nano10091632There is no corresponding record for this reference.
- 52Suchánková, P.; Kukleva, E.; Štamberg, K.; Nykl, P.; Sakmár, M.; Vlk, M.; Kozempel, J. Determination, Modeling and Evaluation of Kinetics of 223Ra Sorption on Hydroxyapatite and Titanium Dioxide Nanoparticles. Mater. 2020, 13, 1915, DOI: 10.3390/ma13081915There is no corresponding record for this reference.
- 53Kukleva, E.; Suchánková, P.; Štamberg, K.; Vlk, M.; Šlouf, M.; Kozempel, J. Surface Protolytic Property Characterization of Hydroxyapatite and Titanium Dioxide Nanoparticles. RSC Adv. 2019, 9, 21989– 21995, DOI: 10.1039/C9RA03698AThere is no corresponding record for this reference.
- 54Suchánková, P.; Kukleva, E.; Štamberg, K.; Nykl, P.; Vlk, M.; Kozempel, J. Study of 223Ra Uptake Mechanism on Hydroxyapatite and Titanium Dioxide Nanoparticles as a Function of PH. RSC Adv. 2020, 10, 3659– 3666, DOI: 10.1039/C9RA08953EThere is no corresponding record for this reference.
- 55Muckley, E. S.; Aytug, T.; Mayes, R.; Lupini, A. R.; Carrillo, J. M. Y.; Goswami, M.; Sumpter, B. G.; Ivanov, I. N. Hierarchical TiO2:Cu2O Nanostructures for Gas/Vapor Sensing and CO2 Sequestration. ACS Appl. Mater. Interfaces 2019, 11, 48466– 48475, DOI: 10.1021/acsami.9b1882455https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1WktrjE&md5=ef2c524a25efd6729fd78cce3aaabbdcHierarchical TiO2:Cu2O Nanostructures for Gas/Vapor Sensing and CO2 SequestrationMuckley, Eric S.; Aytug, Tolga; Mayes, Richard; Lupini, Andrew R.; Carrillo, Jan-Michael Y.; Goswami, Monojoy; Sumpter, Bobby G.; Ivanov, Ilia N.ACS Applied Materials & Interfaces (2019), 11 (51), 48466-48475CODEN: AAMICK; ISSN:1944-8244. (American Chemical Society)We investigate the effect of high-surface-area self-assembled TiO2:Cu2O nanostructures for CO2 and relative humidity (RH) gravimetric detection using polyethylenimine (PEI), 1-ethyl-3-methylimidazolium (EMIM), and polyacrylamide (PAAm). Introduction of hierarchical TiO2:Cu2O nanostructures on the surface of quartz crystal microbalance (QCM) sensors is found to significantly improve sensitivity to CO2 and to H2O vapor. The response of EMIM to CO2 increases 5-fold for 100 nm thick TiO2:Cu2O as compared to gold. At ambient CO2 concns. the hierarchical assembly operates as a sensor with excellent reversibility, while at higher pressures the CO2 desorption rate decreases, suggesting possible application for CO2 sequestration under those conditions. The gravimetric response of PEI to CO2 increases by a factor of 3 upon introduction of a 50 nm TiO2:Cu2O layer. The PAAm gravimetric response to water vapor also increases by a factor of 3 and displays improved reversibility with the addn. of 50 nm TiO2:Cu2O structures. We found that TiO2:Cu2O can be used to lower the detection limits for CO22 sensing with EMIM and PEI and lower detection limits for H2O sensing with RAAm by over a factor of two. Coarse-grained and all-atom mol. dynamics simulations indicate the dissociative character of ionic liq. assembly on TiO2:Cu2O interfaces and different distributions of CO2 and H2O mols. on bare and ionic liq.-coated surfaces, confirming exptl. observations. Overall, our results show high potential of hierarchical assemblies of TiO2:Cu2O / room temp. ionic liq. and polymer films for sensors and CO2 sequestration.
- 56White, F. D.; Thiele, N. A.; Simms, M. E.; Cary, S. K. Structure and Bonding of a Radium Coordination Compound in the Solid State. Nat. Chem. 2024, 16, 168– 172, DOI: 10.1038/s41557-023-01366-zThere is no corresponding record for this reference.
- 57Akamo, D. O.; Kumar, N.; Li, Y.; Pekol, C.; Li, K.; Goswami, M.; Hirschey, J.; LaClair, T. J.; Keffer, D. J.; Rios, O.; Gluesenkamp, K. R. Stabilization of Low-Cost Phase Change Materials for Thermal Energy Storage Applications. iScience 2023, 26, 107175 DOI: 10.1016/j.isci.2023.107175There is no corresponding record for this reference.
- 58Vives, S.; Ramel, D.; Meunier, C. Evolution of the Structure with the Composition and the Defect Arrangement in the Gadolinium and Samarium Doped and Co-Doped Ceria Systems: A Molecular Dynamics Study. Solid State Ionics 2021, 364, 115611 DOI: 10.1016/j.ssi.2021.115611There is no corresponding record for this reference.
- 59Li, P.; Merz, K. M. Metal Ion Modeling Using Classical Mechanics. Chem. Rev. 2017, 117, 1564– 1686, DOI: 10.1021/acs.chemrev.6b0044059https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVSg&md5=1cd2a84bd580b3b4e3493bfdd4bc4da1Metal Ion Modeling Using Classical MechanicsLi, Pengfei; Merz, Kenneth M., Jr.Chemical Reviews (Washington, DC, United States) (2017), 117 (3), 1564-1686CODEN: CHREAY; ISSN:0009-2665. (American Chemical Society)A review. Metal ions play significant roles in numerous fields including chem., geochem., biochem. and materials science. With computational tools increasingly becoming important in chem. research, methods have emerged to effectively face the challenge of modeling metal ions in the gas, aq. and solid phases. Herein we review both quantum and classical modeling strategies for metal ion contg. systems that have been developed over the past few decades. This review focuses on classical metal ion modeling based on unpolarized models (including the nonbonded, bonded, cationic dummy atom, and combined models), polarizable models (e.g., the fluctuating charge, Drude oscillator, and the induced dipole models), the angular overlap model, and valence bond based models. Quantum mech. studies of metal ion contg. systems at the semiempirical, ab initio and d. functional levels of theory are reviewed as well with a particular focus on how these methods inform classical modeling efforts. Finally, conclusions and future prospects and directions are offered that will further enhance the classical modeling of metal ion contg. systems.
- 60Boll, R. A.; Malkemus, D.; Mirzadeh, S. Production of Actinium-225 for Alpha Particle Mediated Radioimmunotherapy. Appl. Radiat. Isot. 2005, 62, 667– 679, DOI: 10.1016/j.apradiso.2004.12.00360https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitFajs7o%253D&md5=e25a534e723a7796e5fc60c2fb21888dProduction of actinium-225 for alpha particle mediated radioimmunotherapyBoll, Rose A.; Malkemus, Dairin; Mirzadeh, SaedApplied Radiation and Isotopes (2005), 62 (5), 667-679CODEN: ARISEF; ISSN:0969-8043. (Elsevier B.V.)The initial clin. trials for treatment of acute myeloid leukemia demonstrated the effectiveness of the alpha emitter 213Bi in killing cancer cells. Bi-213 is obtained from a radionuclide generator system from decay of 10-days 225Ac parent. Recent pre-clin. studies also showed the potential application of both 213Bi, and the 225Ac parent radionuclide in a variety of cancer systems and targeted radiotherapy. This paper describes the 5 years of experience in prodn. of 225Ac in partial support of the on-going clin. trials. A 4-step chem. process, consisting of both anion and cation exchange chromatog., is used for routine sepn. of carrier-free 225Ac from a mixt. of 228Th, 229Th and 232Th. The sepn. of Ra and Ac from Th is achieved using the macroporous anion exchange resin MP1 in 8 M HNO3 media. Two sequential MP1/NO3 columns provide a sepn. factor of ∼106 for Ra and Ac from Th. The sepn. of Ac from Ra is accomplished on a low crosslinking cation exchange resin AG50-X4 using 1.2M HNO3 as eluant. Two sequential AG50/NO3 columns provide a sepn. factor of ∼102 for Ac from Ra. A 60-day processing schedule was adopted to reduce the processing cost and to provide the highest levels of 225Ac possible. Over an 8-wk campaign, a total of ∼100 mCi of 225Ac (∼80% of the theor. yield) is shipped in 5-6 batches, with the 1st batch typically consisting of ∼50 mCi. After the initial sepn. and purifn. of Ac, the Ra pool is re-processed on a bi-weekly schedule or as needed to provide smaller batches of 225Ac. The averaged radioisotopic purity of the 225Ac was 99.6 ± 0.7% with a 225Ra content of ≤0.6%, and an av. 229Th content of (4+5-4)×10-5%.
- 61Huignard, A.; Buissette, V.; Laurent, G.; Gacoin, T.; Boilot, J. P. Synthesis and Characterizations of YVO4: Eu Colloids. Chem. Mater. 2002, 14, 2264– 2269, DOI: 10.1021/cm011263a61https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVarurY%253D&md5=571c98983852a8e5ddeb654056e97f3fSynthesis and Characterizations of YVO4:Eu ColloidsHuignard, A.; Buissette, V.; Laurent, G.; Gacoin, T.; Boilot, J. P.Chemistry of Materials (2002), 14 (5), 2264-2269CODEN: CMATEX; ISSN:0897-4756. (American Chemical Society)A new process for the synthesis of colloidal Eu-doped YVO4 with a particle diam. of ∼10 nm is presented. Nanocrystals are produced by pptn. of citrate complexes of rare earth salts with Na3VO4. NMR and IR studies show that the interaction between citrate ligands and lanthanide ions limits the growth of particles and ensures the stability of the colloidal solns. through electrostatic and steric repulsions. The optimized process leads to stable and highly concd. transparent colloidal solns. in H2O (≤400 g/L).
- 62Young, R. A.. The Rietveld Method; Oxford University Press, 1981.There is no corresponding record for this reference.
- 63Toby, B. H.; Von Dreele, R. B. GSAS-II: The Genesis of a Modern Open-Source All Purpose Crystallography Software Package. J. Appl. Crystallogr. 2013, 46, 544– 549, DOI: 10.1107/S002188981300353163https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFWnu7c%253D&md5=48a7dcdb1d1f10d6f9d7fe3e746d58fdGSAS-II: the genesis of a modern open-source all purpose crystallography software packageToby, Brian H.; Von Dreele, Robert B.Journal of Applied Crystallography (2013), 46 (2), 544-549CODEN: JACGAR; ISSN:0021-8898. (International Union of Crystallography)The newly developed GSAS-II software is a general purpose package for data redn., structure soln. and structure refinement that can be used with both single-crystal and powder diffraction data from both neutron and x-ray sources, including lab. and synchrotron sources, collected on both two- and 1-dimensional detectors. It is intended that GSAS-II will eventually replace both the GSAS and the EXPGUI packages, as well as many other utilities. GSAS-II is open source and is written largely in object-oriented Python but offers speeds comparable to compiled code because of its reliance on the Python NumPy and SciPy packages for computation. It runs on all common computer platforms and offers highly integrated graphics, both for a user interface and for interpretation of parameters. The package can be applied to all stages of crystallog. anal. for const.-wavelength x-ray and neutron data. Plans for considerable addnl. development are discussed.
- 64Thompson, A. P.; Aktulga, H. M.; Berger, R.; Bolintineanu, D. S.; Brown, W. M.; Crozier, P. S.; in’t Veld, P. J.; Kohlmeyer, A.; Moore, S. G.; Nguyen, T. D.; Shan, R.; Stevens, M. J.; Tranchida, J.; Trott, C.; Plimpton, S. J. LAMMPS - a Flexible Simulation Tool for Particle-Based Materials Modeling at the Atomic, Meso, and Continuum Scales. Comput. Phys. Commun. 2022, 271, 108171 DOI: 10.1016/j.cpc.2021.10817164https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXitlSrsb7O&md5=cd0bfd050820e97c11779003add20ed3LAMMPS - a flexible simulation tool for particle-based materials modeling at the atomic, meso, and continuum scalesThompson, Aidan P.; Aktulga, H. Metin; Berger, Richard; Bolintineanu, Dan S.; Brown, W. Michael; Crozier, Paul S.; in 't Veld, Pieter J.; Kohlmeyer, Axel; Moore, Stan G.; Nguyen, Trung Dac; Shan, Ray; Stevens, Mark J.; Tranchida, Julien; Trott, Christian; Plimpton, Steven J.Computer Physics Communications (2022), 271 (), 108171CODEN: CPHCBZ; ISSN:0010-4655. (Elsevier B.V.)Since the classical mol. dynamics simulator LAMMPS was released as an open source code in 2004, it has become a widely-used tool for particle-based modeling of materials at length scales ranging from at. to mesoscale to continuum. Reasons for its popularity are that it provides a wide variety of particle interaction models for different materials, that it runs on any platform from a single CPU core to the largest supercomputers with accelerators, and that it gives users control over simulation details, either via the input script or by adding code for new interat. potentials, constraints, diagnostics, or other features needed for their models. As a result, hundreds of people have contributed new capabilities to LAMMPS and it has grown from fifty thousand lines of code in 2004 to a million lines today. In this paper several of the fundamental algorithms used in LAMMPS are described along with the design strategies which have made it flexible for both users and developers. We also highlight some capabilities recently added to the code which were enabled by this flexibility, including dynamic load balancing, on-the-fly visualization, magnetic spin dynamics models, and quantum-accuracy machine learning interat. potentials.Program Title: Large-scale Atomic/Mol. Massively Parallel Simulator (LAMMPS)CPC Library link to program files:https://doi.org/10.17632/cxbxs9btsv.1Developer's repository link:https://github.com/lammps/lammpsLicensing provisions: GPLv2Programming language: C++, Python, C, FortranSupplementary material:https://www.lammps.orgNature of problem: Many science applications in physics, chem., materials science, and related fields require parallel, scalable, and efficient generation of long, stable classical particle dynamics trajectories. Within this common problem definition, there lies a great diversity of use cases, distinguished by different particle interaction models, external constraints, as well as timescales and lengthscales ranging from at. to mesoscale to macroscopic.Soln. method: The LAMMPS code uses parallel spatial decompn., distributed neighbor lists, and parallel FFTs for long-range Coulombic interactions [1]. The time integration algorithm is based on the Stormer-Verlet symplectic integrator [2], which provides better stability than higher-order non-symplectic methods. In addn., LAMMPS supports a wide range of interat. potentials, constraints, diagnostics, software interfaces, and pre- and post-processing features.Addnl. comments including restrictions and unusual features: This paper serves as the definitive ref. for the LAMMPS code.S. Plimpton, Fast parallel algorithms for short-range mol. dynamics. Phys. 117 (1995) 1-19.L. Verlet, Computer expts. on classical fluids: I. Thermodynamical properties of Lennard-Jones mols., Phys. Rev. 159 (1967) 98-103.
- 65Martinez, L.; Andrade, R.; Birgin, E. G.; Martínez, J. M. PACKMOL: A Package for Building Initial Configurations for Molecular Dynamics Simulations. J. Comput. Chem. 2009, 30, 2157– 2164, DOI: 10.1002/jcc.2122465https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptleqsb8%253D&md5=2a76255c873b866a26540f7e84496272PACKMOL: A package for building initial configurations for molecular dynamics simulationsMartinez, L.; Andrade, R.; Birgin, E. G.; Martinez, J. M.Journal of Computational Chemistry (2009), 30 (13), 2157-2164CODEN: JCCHDD; ISSN:0192-8651. (John Wiley & Sons, Inc.)Adequate initial configurations for mol. dynamics simulations consist of arrangements of mols. distributed in space in such a way to approx. represent the system's overall structure. In order that the simulations are not disrupted by large van der Waals repulsive interactions, atoms from different mols. must keep safe pairwise distances. Obtaining such a mol. arrangement can be considered a packing problem: Each type mol. must satisfy spatial constraints related to the geometry of the system, and the distance between atoms of different mols. must be greater than some specified tolerance. We have developed a code able to pack millions of atoms, grouped in arbitrarily complex mols., inside a variety of three-dimensional regions. The regions may be intersections of spheres, ellipses, cylinders, planes, or boxes. The user must provide only the structure of one mol. of each type and the geometrical constraints that each type of mol. must satisfy. Building complex mixts., interfaces, solvating biomols. in water, other solvents, or mixts. of solvents, is straightforward. In addn., different atoms belonging to the same mol. may also be restricted to different spatial regions, in such a way that more ordered mol. arrangements can be built, as micelles, lipid double-layers, etc. The packing time for state-of-the-art mol. dynamics systems varies from a few seconds to a few minutes in a personal computer. The input files are simple and currently compatible with PDB, Tinker, Molden, or Moldy coordinate files. The package is distributed as free software and can be downloaded from . © 2009 Wiley Periodicals, Inc. J Comput Chem, 2009.
- 66Qiao, B.; Skanthakumar, S.; Soderholm, L. Comparative CHARMM and AMOEBA Simulations of Lanthanide Hydration Energetics and Experimental Aqueous-Solution Structures. J. Chem. Theory Comput. 2018, 14, 1781– 1790, DOI: 10.1021/acs.jctc.7b0101866https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1Ojs7o%253D&md5=4584c2953f83d9c9d8dc894503df8d98Comparative CHARMM and AMOEBA Simulations of Lanthanide Hydration Energetics and Experimental Aqueous-Solution StructuresQiao, Baofu; Skanthakumar, S.; Soderholm, L.Journal of Chemical Theory and Computation (2018), 14 (3), 1781-1790CODEN: JCTCCE; ISSN:1549-9618. (American Chemical Society)The accurate understanding of metal ion hydration in solns. is a prerequisite for predicting stability, reactivity, and soly. Herein, additive CHARMM force field parameters were developed to enable mol. dynamics simulations of lanthanide (Ln) speciation in water. Quant. similar to the much more resource-intensive polarizable AMOEBA potential, the CHARMM simulations reproduce the exptl. hydration free energies and correlations in the first shell (Ln-oxygen distance and hydration no.). Comparisons of difference pair-distribution functions obtained from the two simulation approaches with those from high-energy x-ray scattering expts. reveal good agreement of first-coordination sphere correlations for the Lu3+ ion (CHARMM only), but further improvement to both approaches is required to reproduce the broad, non-Gaussian distribution seen from the La3+ expt. Second-coordination sphere comparisons demonstrate the importance of explicitly including an anion in the simulation. This work describes the usefulness of less resource-intensive additive potentials in some complex chem. systems such as soln. environments where multiple interactions have similar energetics. In addn., 3-dimensional descriptions of the La3+ and Lu3+ coordination geometries are extd. from the CHARMM simulations and generally discussed in terms of potential improvements to solute-structure modeling within soln. environments.
- 67Priest, C.; Zhou, J.; Jiang, D.; en Solvation of the Vanadate Ion in Seawater Conditions from Molecular Dynamics Simulations. Inorg. Chim. Acta 2017, 458, 39– 44, DOI: 10.1016/j.ica.2016.12.02767https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFWqsQ%253D%253D&md5=73b646e8a40212385ebbb517a009c2b4Solvation of the vanadate ion in seawater conditions from molecular dynamics simulationsPriest, Chad; Zhou, Jingwei; Jiang, De-enInorganica Chimica Acta (2017), 458 (), 39-44CODEN: ICHAA3; ISSN:0020-1693. (Elsevier B.V.)One of the current challenges present in uranium extn. from seawater is the competitive sorption of vanadium. But compared with uranium, much less is known about the solvation and speciation of the vanadate ion in seawater. Herein, we utilize both first principles mol. dynamics and classical mol. dynamics simulations to provide a microscopic insight into the solvation of the HVO42- ion in pure water and in seawater. In pure water, we found that the dianion state is the most probable structure. But in a simulated seawater with 0.55 M NaCl, the NaHVO4- ion is most probable, followed by the neutral Na2HVO4; averaging over 100-ns trajectory, the coordination no. of Na+ ions around V was found to be 1.5 within a radius of 4.0 Å. We found that the NaHVO4- ion can exist in two interchangeable states: a bidentate state where the Na+ ion interacts directly with two vanadate oxo groups; a monodentate where the Na+ ion interacts with only one vanadate oxo group. From this monodentate state, the Na+ ion can further dissoc. away with a free-energy barrier of 2.5 kcal/mol. Our work therefore demonstrates that Na+ ions are closely assocd. with the vanadate species in seawater.
- 68Clark, G. N. I.; Cappa, C. D.; Smith, J. D.; Saykally, R. J.; Head-Gordon, T. The Structure of Ambient Water. Mol. Phys. 2010, 108, 1415– 1433, DOI: 10.1080/0026897100376213468https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFylsL4%253D&md5=e87f8ea16df8cad26657f690cf069875The structure of ambient waterClark, Gary N. I.; Cappa, Christopher D.; Smith, Jared D.; Saykally, Richard J.; Head-Gordon, TeresaMolecular Physics (2010), 108 (11), 1415-1433CODEN: MOPHAM; ISSN:0026-8976. (Taylor & Francis Ltd.)We review the spectroscopic techniques and scattering expts. used to probe the structure of water, and their interpretation using empirical and ab initio models, over the last 5 years. We show that all available scientific evidence overwhelmingly favors the view of classifying water near ambient conditions as a uniform, continuous tetrahedral liq. While there are controversial issues in our understanding of water in the supercooled state, in confinement, at interfaces, or in soln., there is no real controversy in what is understood as regards bulk liq. water under ambient conditions.
- 69Goswami, M.; Kumar, N.; Li, Y.; Hirschey, J.; LaClair, T. J.; Akamo, D. O.; Sultan, S.; Rios, O.; Gluesenkamp, K. R.; Graham, S. Understanding Supercooling Mechanism in Sodium Sulfate Decahydrate Phase-Change Material. J. Appl. Phys. 2021, 129, 245109 DOI: 10.1063/5.0049512There is no corresponding record for this reference.
Supporting Information
Supporting Information
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.3c13213.
Description of MD simulations in detail; force-field parameters (Lennard-Jones) used in the MD simulations; RDF of water in LnVO4 and the comparison of the RDF of La, Eu, and oxygen of VO4; RDF of Ac-/Ra-doped lanthanide at different temperatures and the snapshots; Rietveld analysis parameters and XRD patterns; summary of the molar ratio of the nanoconstructs; excitation and emission spectra of 225Ac-doped nanoconstructs and 30 days' decayed 225Ac-doped nanoconstructs, respectively; and different compositions of lanthanides (PDF)
Terms & Conditions
Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.